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 Store-operated Ca2+ entry (SOCE), the important cellular process in a wide range of cell types 
and species, is mediated by stromal interaction molecule (STIM), which senses the depletion of 
endoplasmic reticulum Ca2+ stores and binds and activates Orai channels in the plasma membrane. This 
inside-out mechanism of Ca2+ signaling raises some interesting questions about the SOCE: how did this 
sensitive Ca2+ signaling regulated by these two proteins existing in different cellular compartments?  
In this paper, I clarified the molecular insights into the gating mechanism and function of SOC 
channel by investigated the gating mechanism of Caenorhabditis elegans Orai channels and investigated 
the function of STIM2, an eight-residue-inserted splice variant of STIM2, in myogenesis. My analysis 
revealed a mechanism of Orai gating by STIM binding to the intracellular 2-3 loop of Orai in C. elegans 
that is radically different from Orai gating by STIM binding to the N and C termini of Orai in mammals. 
Besides, I found that the conserved hydrophobic amino acids in the 2-3 loop of Orai1 are essential for 
the oligomerization and gating of channels and are regulated via an intramolecular interaction 
mechanism mediated by the N and C termini of Orai1. Also, I found that the STIM2 splicing was 
increases during in vitro differentiation of skeletal muscle. This study I investigated the function of 
STIM2 in myogenesis with RNA interference-mediated knockdown and CRISPR-Cas-mediated 
knockout approaches. Deletion of STIM2 delayed myogenic differentiation through the MEF2C and 
NFAT4 pathway in C2C12 cells. Further, loss of STIM2 increased cell proliferation by altering Ca2+ 
homeostasis and inhibited cell cycle arrest mediated by the cyclin D1-CDK4 degradation pathway. 
Taken together, these data identified a previously unknown the molecular insights into the gating 
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 Calcium signaling is the mainly evolutionarily preserved and universal signaling mechanism 
(1). A numerous cellular process, including muscle contraction, secretion, cell growth, cellular motility, 
and muscle development was regulated by a varied array of calcium signaling pathways. The 
intracellular organelles and calcium entry control the Intracellular Calcium concentration. Store-
operated Ca2+ entry (SOCE) in the plasma membrane has newly been shown to perform as an important 
intracellular Ca2+ entry mechanism mediating cellular processes such as cell differentiation and Ca2+ 
homeostasis. The ER Ca2+ stores depletion activates SOCE, and the calcium release-activated calcium 
(CRAC) channel, which has low unitary conductance and high Ca2+ selectivity, is evolutionary 
conserved from C. elegans to mammal and the most considerably studied SOCE channel (2-6). It is 
thought that SOCE arises early in the evolution, allowing various preserved physiological functions to 
be carried out, but it remains elusive whether the molecular mechanisms that underlie SOCE are 
conserved across evolution.  
 
 
Figure 1. Introduction of SOCE 
 
 In recent years, the molecular mechanism by which CRAC channel is activated by ER Ca2+ 
depletion activates has been well demonstrated in mammals (7-9). When various cellular stimuli deplete 
ER Ca2+ stores, STIM1 begins to form ordered oligomers, expanding its activation domain (CAD, OASF, 
SOAR, Ccb9) (10-13) and relocating to puncta tightly localized to ER-PM junctions, binding and 
activating Orai1 (14-16) . Orai1 also goes through re-localization from a diffuse plasma membrane 
localization to puncta colocalization with STIM1 upon STIM1 activation while this progress (2, 17-19). 
And Orai1 complex is established to form the hexameric structure of trimer of dimers and dimer of C-
termini of Orai1 contact with an antiparallel direction (3, 20, 21). Nonetheless, the interaction of Orai1 
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C-termini is a weak interaction due to it has never been detected by coimmunoprecipitation approaches 
(22-25). 
C.STIM1 and C.Orai1, mammalian STIM1 and Orai1 orthologues, respectively, have been 
identified in C. elegans. Also, some studies explore their expression and function in various tissues 
(neurons, gonadal, sheath cells, intestine, and spermatheca) (26, 27). Similar to the recognized functions 
of mammalian SOCE, the molecular properties and biophysical functions of STIM1 and Orai1 in C. 
elegans are thought to be vital for the maintenance of ER Ca2+ stores and intracellular Ca2+ signaling. 
However, there have been reported some differences between C.STIM1 and mammalian STIM1 (28). 
First, in contrast to C.STIM1, which pre-localized puncta close to the PM even before ER calcium store 
depletion, H.STIM1 exists as diffusely distributed in the ER (26, 27). Second, C.STIM1 does not 
contain a polybasic sequence motif at its C-terminus; in mammalian STIM1, this sequence contributes 
to PM localization by promoting interaction with phosphoinositides. These differences between 
C.STIM1 and H.STIM1 drive me to raise the question that whether the molecular mechanism of STIM1 
function has been conserved through evolution, although from C. elegans to human, Store-operated 
calcium entry is a quite preserved and crucial cellular signaling pathway. 
 In this study I report a novel mechanism of C. elegans SOCE that is quite different from the 
previous findings demonstrating a minimal CRAC activation domain (CAD) in human STIM1 that 
binds directly to and activates Orai1 at binding sites in the N and C termini of Orai1. Here I show that 
C.STIM1 also has a CAD (C.CAD) that is both necessary and sufficient for C.Orai1 activation. C.CAD 
binds directly to a different binding site, however, the 2-3 loop of C.Orai1. I also demonstrate that the 
2-3 loop of C.Orai1 plays a crucial role in C.Orai1 oligomerization and regulation of C.SOCE. Mutating 
two conserved amino acids (FY) in invertebrate Orai1 to conserved vertebrate amino acids (RH) also 
revealed a novel SOCE mechanism by which C.Orai1 induces oligomerization and produces a 
constitutively active channel. This amino acid change appears to induce oligomerization of C.Orai1 by 
promoting the interaction of C.Orai1 subunit 2-3 loops. Molecular dynamics simulations demonstrate 
large volume fluctuation of the N-terminus of C.Orai1 compared to other Orai1 domains, and 
immunoprecipitation analysis shows that the N-terminus of C.Orai1 binds to wild-type, but not mutated, 
2-3 loop of constitutively active of C.Orai1, implying that the activity of the 2-3 loop of C.Orai1 is 
regulated by the C.Orai1 N-terminus via an intramolecular interaction. Circular permutation Venus 
(cpVenus) fluorescent protein has been shown to be sensitive to environments, such as pH and structural 
changes. I added an internal sequence encoding cpVenus in the N-terminus of C.Orai1. cpVenus-
C.Orai1 shows little or no fluorescence at rest, but upon store depletion, cpVenus fluorescence increases 
and begins to associate with STIM1 into puncta. This induced conformational change in the N-terminus 
of C.Orai1 is mediated by the intramolecular hydrophobic interaction between the N-terminus and the 
2-3 loop of C.Orai1. Together, my results demonstrate a mode of SOCE activation in C. elegans that is 
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distinct from mammalian SOCE and provide a better understanding of the molecular mechanism that 
could be targeted for developing peptide or chemical invertebrate SOCE regulators. 
Also, I report a novel gating mechanism of C. elegans Orai1 channels which is different from 
my previously reported mechanism of human SOCE. I found that the gating of Orai1 channels by STIM 
binding to the intracellular 2-3 loop in C. elegans is quite different from Orai gating by STIM binding 
to N- and C-terminus of Orai in mammals. Moreover, the conserved hydrophobic amino acids in the 
intracellular 2-3 loop of C.Orai1 play a critical role in the oligomerization and gating of channels via 
an intramolecular switch mechanism by its N- and C-terminus of C. elegans Orai1. This study identifies 
a previously unknown SOCE mechanism in C. elegance indicating that the gating mechanisms 
underlying SOCE have diverged from invertebrates to mammals during evolution and provides a better 
understanding of the molecular mechanism that could be targeted for developing peptide or chemical 
invertebrate SOCE regulators. 
 The identification of the two key mediators of SOCE, STIM and ORAI, has dramatically 
advanced our understanding of how SOCE is activated and inactivated. Stromal interaction molecule 1 
(STIM1) is a single transmembrane ER Ca2+ sensor dispersed in the endoplasmic reticulum (ER) that 
activates Orai channels inhabiting the plasma membrane (1, 29). Orai1 is a plasma membrane Ca2+ 
channel with four transmembrane domains that comprises the pore subunit of SOCE (21, 30, 31).  
 Although STIM family (STIM1 and STIM2) respond similarly to store depletion, STIM2 
differs from STIM1 in being partially localized at ER-PM junctions even in store-replete cells, likely 
as a result of its lower affinity for ER Calcium relative to STIM1. Whether the effect of STIM2 on 
SOCE is activation or inhibition is controversial, and a recent published data shows that regulation of 
basal calcium homeostasis did not consider a role of STIM2. In addition to its role in maintaining basal 
calcium and controlling ER calcium levels, STIM2 activates Orai1 signaling upon submaximal store 
depletion, driving calcium oscillations due to partially pre-coupled STIM2-Orai1 population (32, 33). 
STIM2 and Orai1 form a calcium-sensitive and thapsigargin-insensitive complex in cortical neurons, 
with loss of STIM2-protecting neurons from store-mediated hypoxic neuronal death.  
The recently identified spliced isoform of STIM2, STIM2 (also known as STIM2.1), is highly 
conserved and acts as a potent inhibitor of SOCE (34, 35). STIM2 contains an additional eight amino 
acids in CRAC activation domains and forms a heterodimer with other STIM isoforms to inhibit 
calcium release-activated calcium (CRAC) channels through an allosteric mechanism (36). Through 
this alternative splicing of STIM2, the cells can effectively control the calcium homeostasis by 
preventing Orai1 channel cross-linking and regulate the balance between SOCE activators and 






Figure 2. STIM2 alternative spliced forms 
 
 In this study, I explored the physiological role and effects of STIM2 in myogenesis (32, 33). 
myogenesis is the process by which somatic cells from mature muscle tissue through a series of complex 
regulated processes of proliferation, cell cycle arrest, and differentiation. Numerous signaling pathways 
help to precisely control these stages (37-40). The mitogen-responsive signal then degrades cyclin D1 
and its catalytic partner CDK4 to induce exit of the cell from the G1 phase to enter the G0 phase, a 
quiescent post-mitotic stage. Further, myogenesis marker genes such as myosin heavy chain (MHC), 
which was first identified in the nuclei of myotube, is a main regulator of muscle development (41, 42). 
Using C2C12 cells with STIM2 knockdown or knockout approaches, I explored the effects of STIM2 
loss or deficiency on the key regulators of myogenesis, including the NFAT4 and MEF2C signaling 
pathway, along with its effects on calcium homeostasis and cell cycle arrest via analysis of changes in 
the expression of cyclin D1 and CDK4 (40, 43-45). These results suggest that the STIM2 signaling 
pathway serves as a switch cell fate between proliferation and skeletal muscle differentiation. Also this 
study provides a novel insight into the molecular interactions and roles of splicing events in the 









Fura-2/AM, Lipofectamine 2000 were obtained from Invitrogen. Thapsigargin (TG) and phorbol 12-
myristate 13-acetate (PMA) were from Santa Cruz. 2-Aminoethoxy diphenyl borate (2-APB) were from 
Sigma-Aldrich. Anti-Flag M2 affinity gel was obtained from Sigma. Antibodies targeting GFP (598, 
MBL), Flag (M2, F1804, Sigma) were purchased from the indicated vendor. 
 
2.2. NFAT nuclear translocation assay 
 
HEK 293 cells were cultured on poly-ornithine coated 15mm round cover glass. GFP-NFAT1 was 
transfected into cells with indicated constructs. The culture medium was changed after 2hr and cells 
incubated for 18-24hr. The cells were washed with PBS three times and fixed with 4% 
paraformaldehyde and mounted with Aqua polyMount solution (polyscience) at room temperature. The 
cells were imaged using IX83 microscope equipped with an Olympus x40 objective lens (oil, NA 1.30), 
fluorescent lamp (Olympus), stage controller (LEP) and CCD camera (ANDOR). Images were analyzed 
using Fiji software. 
 
2.3. NFAT-luciferase assays 
 
HEK 293T cells were transfected with NFAT reporter gene and the indicated constructs. 
Cotransfection with the Renilla luciferase gene (pRLTK) was used as an internal control for cell number 
and transfection efficiency. After 12-18hr incubation, cells were treated with dimethyl sulfoxide 
(DMSO), phorbol 12-myristate 13-acetate (PMA; 1μM), or PMA + TG (1μM) for 4-8 hr. Assays were 
performed by the Dual Luciferase Reporter Assay System (Promega). For each condition, luciferase 
activity was measured with samples taken from duplicate wells with a 96-well automated luminometer 
(Bio-rad). Results are calculated as the ratio of firefly to Renilla luciferase activity. 
 
2.4. Immunoprecipitation and Immunoblot analysis 
 
HEK 293T cells were transfected with the indicated constructs for 12-24 hr. Transfected cells washed 
with PBS three times and lysed by 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 % Triton X-100. Lysates 
were centrifuged at 12,000 rpm for 10 min, and the supernatant was incubated at 4°C with anti-Flag M2 
agarose beads (Sigma) for overnight. Lysates and immunoprecipitated samples were run on an SDS-
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PAGE, probed with horseradish peroxidase (HRP)-conjugated secondary antibody, and detected by 
enhanced chemiluminescence (Pierce). 
 
2.5. Confocal Microscopy 
 
Confocal fluorescence images were acquired on LSM780 (Zeiss, NLO) confocal microscope with a 
Zeiss x100 objective lens (oil, NA 1.46). mCherry and eGFP were excited simultaneously at 594 nm 
and 488 nm, respectively. Fluorescence emission was collected at 615-840 nm (mCherry) and 510-570 
nm (eGFP). Zen software (Zeiss) was used for image acquisition. All experiments were performed at 
25℃. 
 
2.6. TIRF Microscopy 
 
TIRF fluorescence Images were acquired with an Olympus inverted microscope IX81-ZDC with 
Cell^TIRF equipped with an Olympus UAPO 60x TIRF oil immersion objective (NA 1.49) and CCD 
camera (ANDOR). Cells were excited with the 488 or 594 nm, and fluorescence emission was collected 
at 485 nm (eGFP) and 575 nm (mCherry). Xcellence software (Olympus) was used for image 
acquisition. All experiments were performed at 25℃. Venus fluorescence was detected with a 100mW, 
514 laser line with a 546 nm filter.  
 
2.7. Intracellular Calcium imaging 
 
Cells were loaded with 1μM Fura-2/AM in DMEM at 37℃ for 30min. Ratiometric Ca2+ imaging 
was performed at 340 and 380 nm in 0 or 2 mM Ca2+ Ringer’s solution with a IDX81 microscope 
(Olympus) equipped with an Olympus x40 oil (NA 1.30) objective equipped with a fluorescent arc lamp 
(LAMDA LS), excitation filter wheel (SUTTER, LAMBDA 10-2), stage controller (ASI, MS-2000) 
and a CCD camera (HAMAMATSU, C10600) at room temperature. Images were processed with 
Metamorph and analyzed with Igor Pro. 
 
2.8. Fluorescence Recovery After Photobleaching 
 
Images were acquired on LSM780 confocal microscope with Zeiss x63 oil lens (NA 1.46) at room 
temperature. Pre-bleach and recovery images were scanned at 488 nm at 2% power. A 0.4μm diameter 
circle was bleached with a full transmission for ~ 2 s. Bleaching during the recovery period was 
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Patch clamp experiments conditions as previously described(11). Briefly, HEK 293 cells were 
transfected 12-24hr prior to electrophysiology experiments with indicated constructs by Lipofectamine 
2000. Currents were recorded via standard whole-cell patch clamp techniques(46). Pipettes of resistance 
2-5 MΩ were filled with an internal solution containing 150mM Cs-aspartate, 8 mM MgCl2, 10 mM 
EGTA, and 10 mM HEPES (pH 7.2 with CsOH). Currents were sampled at 5 kHz and filtered at 2 kHz, 
and all voltages were corrected for the junction potential of the pipette solution relative to Ringer’s in 
the bath (-13mV). Data analysis was done with OriginPro software (OriginLab).  
 
2.10. SPR-binding assays 
 
SPR was performed with BIAcore T200 instrument (GE Healthcare). All recombinant proteins were 
purified and analyzed with SDS-PAGE. GST-2-3 loop of C.Orai1 was captured on CM5 S chip surfaces 
(GE Healthcare). 6xHIS tagged C.CAD was used as an analyte with variant concentrations. Binding 
assays were performed by injecting two-fold serial dilutions of an analyte in HBS-EP buffer (GE 
Healthcare) at a flow rate of 30 μl per min (kinetic experiments). Surfaces were regenerated by a brief 
injection of 50 mM sodium hydroxide (60s contact time at a flow rate of 60 ul per min). 
 
2.11. Molecular dynamics simulations 
 
Atomistic model for C. elegans orai (C.Orai1) was built based on homology modeling where the 
crystal structure of the Drosophila melanogaster Orai1(dOrai1) channel (PDB ID: 4HKR) was used as 
a template. Given the amino acid sequences of wild-type C.Orai1, a complete atomistic model was 
constructed using I-TASSER(47) web server by which the C.Orai1 protein’s starting coordinates for 
molecular dynamics (MD) was obtained.   
C.Orai1 wild-type protein monomer was embedded in a phosphatidylcholine (POPC) lipid bilayer and 
solvated with TIP3 model water and neutralized with sodium and chloride ions to yield a concentration 
of 150 mM NaCl. Simulation box size is 100Å*75Å *92Å and contains ~ 74000 atoms in total. This 
procedure of building an initial structure for MD was done with VMD, and protocols for minimization, 
annealing, equilibration and successive MD runs are prepared by QwikMD(48). Resulting MD system 
was simulated by 2.11 version of NAMD molecular dynamics package(49) in the constant pressure and 
temperature (NpT) condition. Pressure was maintained at 1 atm using Langevin piston algorithm with 
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an oscillation and damping timescale of 200fs and 100fs, respectively and the temperature was kept at 
300 K using Langevin dynamics. A distance cut-off of 12.0 Å was applied to short-range, non-bonded 
interactions, and 10.0 Å for the smothering functions. The particle-mesh Ewald (PME) was used in 
treating long-range electrostatic interactions. For integration equation of motion, r-RESPA multiple time 
step scheme(49) was employed so that it could update the short-range interactions every 1 steps and 
long-range electrostatics interactions every 2 steps. Time step for integration is chosen to be 2 fs. 
SHAKE/RATTLE algorithms is utilized in constraining all bonds connected to hydrogens. Root mean 
square deviation (RMSD) of protein is calculated to determine whether the MD system reaches 
equilibrium or not. Root mean square fluctuation (RMSF) of protein residues was obtained from the 
data points of MD simulation whose RMSD values are stable. 
 
2.12. Fluorescence Resonance Energy Transfer experiment 
 
Fluorescence resonance energy transfer (FRET) assay was performed by previous studied method 
(50, 51). Fused proteins were expressed in HEK 293 cells using Lipofectamine 2000 (Life 
Technologies). Image acquired on an LSM780 microscope, Zeiss x63 oil lens (NA 1.46) at room 
temperature. For mClover3, 488 nm laser excitation was used, with 500-600 nm light collected, for 
mRuby3, 559 nm laser excitation was used, with 570-670 nm light collected. For FRET signal, 488 nm 
laser excitation was used, with 570-670 nm light collected. To calculate FRET signal, use metamorph 
software FRET journal (FRET= IrawFRET − (BDonor * IDonor) − (BAcceptor * IAcceptor), B = bleed-trough 
correction factors as determined by separate experiments using mClover3 only or mRuby3 only). 
 
2.13. Cell Culture and transfection 
 
HEK293, C2C12 and HEK293T cells were cultured in DMEM supplemented with 10% FBS at 37℃ 
in 5% CO2. For patch clamping, Flp-In T-Rex stable HEK293 cells expressing GFP-myc-H.Orai1 and 
cherry-H.STIM1 (Invitrogen) were maintained with 50 g/ml of hygromycin. For the muscle cell 
differentiation, C2C12 myoblast cells were cultured to 70-80% confluency and then change cultured 
media to DMEM containing 2% horse serum and changed the medium every day. For transient 
transfection, the cells were transfected at 70% confluency with 0.3-3g DNA using Lipofectamine 2000 
and Jet Prime (Life Technology and PolyPuls) according to the manufacturer’s instructions. STIM1-
KO U-2 OS cells were very kindly provided by Franscisco Javier Martin-Romero (University of 




2.13. mRNA expression level check 
 
Total RNA was extracted from cells using RiboEx (GeneAll) following the manufacturer’s protocol. 
cDNA was made from 2~3 g of RNA reverse transcribed using oligo (dT) primers and First Strand 
cDNA Synthesis Kit (TOYOBO). The PCR amplification was done using a C1000 Touch thermal 
Cycler (Bio-Rad). Amplification started with initial denaturation at 95℃ for 3min and then 30-40 
cycles of denaturation at 95℃ for 30 sec, annealing at 55℃ for 30sec, and extension at 72℃ for 1min. 
Gel electrophoresis was used to identify the PCR products in a 1.5% agarose gel using ethidium bromide 
staining. For real-time quantitative PCR analysis, synthesized cDNA and SYBR green Master Mix 
(Roche) were run on a LightCycler480 II (Roche). Relative expression levels of mRNA were calculated 
using the 2 – Ct method (45 sci).  
 
  
2.14. Generation of knockout cell line with CRISPR/Cas9 
 
Guide RNA sequences for mouse STIM2 (5’-CCTGCAGGTTAGTAGTTACTAGA-3’) are inserted 
in pRGEN vector and pRGEN-reporter (ToolGen). C2C12 cells were transfected with pRGEN-
mSTIM2 , pRGEN-Cas9, and pRGEN-reporter using Lipofectamine 2000, according to the 
manufacture’s instructions. Two days after transfection, cells were selected with 1000 μg/ml of 
hygromycin for four days. After one week, colonies were an isolated and genomic deletion, and mRNA 




C2C12 cells were seed on Collagen coated glass and induce differentiation. Every indicated timepoint, 
the cells were fixed with 4% paraformaldehyde for 10min and treated with 0.1% Triton X-100 in PBS 
for 10min at room temperature, and then block with 3% BSA in PBS for 2hr. Following incubation with 
the indicated antibody over night at 4℃, cells were incubated with a conjugated secondary antibody at 
37℃ for 1hr. Finally, the nuclei were stained with Hoechest (Molecular Probes) for 5min. 
 
2.16. EdU staining 
 
Cell-cycle analysis was performed by assaying the incorporation of 5-ethynyl-2’-deoxyuridine (EdU) 
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according to the manufacturer’s instruction (Invitrogen). Briefly, cells were cultured in medium 
containing 1X EdU component for an additional time, as indicated. Following incubation, the cells were 
rinsed with PBS and fixed with 4% PFA for 15 mins at RT. 
 
2.17. MTT assay. 
 
C2C12 cells were seeded at a density of 7500 cells/well in 96-well plates. Next day, cells were 
incubated with medium containing 1mg/ml of MTT. After 4hr incubation at 37℃, The medium was 
then aspirated and add DMSO and gently shake 15min for formazan solubilization. The absorbance was 
measured at a wavelength of 562 nm by using a fluorescence plate reader (Spectra MAX Pro 5, 




All statistical analysis was performed in Prism 6 (GraphPad Software). All error bars represent SEM. 
All pairwise differences were tested for significance using a two-tailed t test. At least three independent 
experiments were performed. P-values < 0.05 were considered statistically significant and indicated as 




mCherry-H.STIM1 and EGFP-H.Orai1 plasmids were described previously(19). mCherry-H.CAD, 
GFP-NFAT, NFAT-firefly-Luciferase reporter and pRLTK plasmids were described previously(11). 
C.STIM1 and C.Orai1 were amplified by PCR using C. elegans CDNA library and primer sets shown 
below. The PCR products were cloned into pCR8-GW-TOPO cloning vector (Invitrogen). A KpnI site 
at N-terminus of C.STIM1 was generated to preserve signal sequence using primer sets shown below 
and the QuickChange XL site-directed mutagenesis kit (Agilent Technologies). Entry clones of 
C.STIM1 and C.Orai1 constructs were transferred to the destination vectors by Gateway LR clonase 
reactions (Invitrogen, Carlsbad, Califonia) to generate the expression constructs. All plasmids were 
sequenced to verify the constructs.  
 
















































C.Orai1 (NT, CT) 
 
Forward: 5-ggatccgccaccatgacgtcagcacttctggcagg -3 
Reverse: 5-agatctttaactgaacaccacgaatacaactc-3 
 
For C.Orai1 (FY-RH) and 2-3 loop (FY-RH) and M3 peptide (FY-RH; F192R, Y193H) 
 
C.Orai1 (FY-RH; F192R, Y193H) mutation was generated by substituting nucleotides at 574 (t→c), 





For C.Orai1 (FY) 
 
C.Orai1 (FY; F192, Y193) mutation was generated by deleted nucleotides at 574 (t), 575(t), 576(c), 
577(t), 578(a) and 579(c). 
 
Forward: 5-gattctccgcatattaagttgaagattgatctgtcatggc -3 
Reverse: 5-gccatgacagatcaatcttcaacttaatatgcggagaatc -3 
 
For C.Orai1 (FF-AA) and cpVensus-C.Orai1 and NT (FF-AA; F56A, F57A) 
 









C.Orai1 (V271S) and (V271D) mutation was constructed by substituting nucleotides at 811 (g→t for 
V271S), 812 (t→c for V271S and t→a for V271D) and 813 (g→c for V271D).  
 










For C.Orai1 (M274S) and C.Orai1 (M274D) 
 
C.Orai1 (M274S) and (M274D) mutation was constructed by substituting nucleotides at 820 (a→t for 
M274S and a→g for M274D), 821 (t→c for M274S and t→a for M274D) and 822 (g→c for M274D).  
 





For C.Orai1 (M274D) 
 
Forward: 5- gcataaggtggacacatcgaagcagttccttgacgt-3 
Reverse: 5- acgtcaaggaactgcttcgatgtgtccaccttatgc-3 
 
For M3-3, M3-6 and M3-9 
 
M3-3, M3-6 and M3-9 constructs constructed were by substituting nucleotide to stop codon (tga). 
 
C.Orai1 M3-3 (2-3 loop fragment, 184-196) 
 
Forward: 5- ttctacattgatctgtgatggctctga -3 
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Reverse: 5- tcagagccatcacagatcaatgtagaa -3 
 
C.Orai1 M3-6 (2-3 loop fragment, 184-193) 
 
Forward: 5-ttgaagttctactgagatctgtcatgg-3 
Reverse: 5- ccatgacagatctcagtagaacttcaa-3 
 





The M2 domain of C.Orai1 2-3 loop construct was generated by adding stop codon in pCR8-C.Orai1 
2-3 loop cytosolic construct by site-directed mutagenesis using primers as shown below. The M3 of 
C.Orai1 2-3 loop construct was made by primer annealing. Annealing products were sub-cloned into 
the customized vector by T4 ligation reaction (New England Biolabs). The expression vectors were 
made by Gateway LR Clonase reaction (Invitrogen) 
 












To generate cpVenus, the C-terminal portion of Venus (amino acids 155–238) and N-terminal portion 
of Venus (amino acids 1–172) were PCR amplified using Venus as a template and the prime sets are 
shown below. A flexible linker sequence (GSG) was added to minimize potential perturbations of 
cpVenus and C.Orai1 N-terminus. To construct internal cpVenus-C.Orai1, the mutation was generated 
by substituting nucleotides at 325 (t→g) 326 (t→g) of C.Orai1 and BamHI site was created. cpVenus 
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was inserted at between A64 and G65 of C.Orai1 to generate cpVenus-C.Orai1. And desired mutations 
were further performed to generate cpVenus-C.Orai1 (FY-RH), and cpVensu-C.Orai1 (FF-AA). 
 












To generate cpVenus-65-C.Orai1, PCR amplification was performed using cpVenus-C.Orai1 as a 





For FRET construction 
 
The mRuby3 and mClover3 were subcloned to C.Orai1 or C.STIM1 and mRuby3 and mClover3 were 







3.1. Distinct gating mechanism of SOC channel involving STIM-Orai coupling and an 
intramolecular interaction of Orai in Caenorhabditis elegans. 
 
3.1.1. C. elegans STIM1 activates C. elegans Orai1 but not human Orai1  
 
I examined whether SOC channel complex composed of STIM and Orai proteins has been 
maintained their functional combination for diverse Ca2+ signaling during the evolution from 
invertebrates to vertebrates. I tested the cross activity of SOCE complex from human and C. elegans as 
a representative of vertebrate and invertebrate, respectively.  
I initially investigated whether C. elegans STIM1 (C.STIM1, hereafter) could activate both human 
Orai1 (H.Orai1, hereafter) and C. elegans Orai1 (C.Orai1, hereafter). Human Embryonic Kidney (HEK) 
293 cells transiently expressing C.STIM1 and C.Orai1 generated an intracellular Ca2+ rise after 
treatment of the cells with 1μM thapsigargin (TG) to deplete internal ER Ca2+ store in a different system 
(Figure 1A). However, these cells expressing C.STIM1 and H.Orai1 showed no further store-operated 
Ca2+ influx, indicating C.STIM1 causes a Ca2+ rise through the same species C.Orai1 but not with other 
species channels like H.Orai1. The peak of the Ca2+ rise by C.STIM1 through C.Orai1 or H.Orai1 
showed the reciprocal activity of C.STIM1 on different Orai1 channels (Figure 1B). I next examined 
the reverse effect of human STIM1 (H.STIM1, hereafter) on C.Orai1 activation. I introduced HEK 293 
cells with H.STIM1 along with either H.Orai1 or C.Orai1 and measured an intracellular Ca2+ rise with 
TG treatment. H.STIM1 elevated a Ca2+ rise only with H.Orai1, but not with C.Orai1 (Figure 1C), and 
the peak of Ca2+ rise showed the favorite activity of H.STIM1 on different Orai1 channels (Figure 1D). 
These results indicated that the activation mechanism of C.Orai1 by C.STIM1 could be different from 
that of human Orai1 and need to examine in more detail. 
The Ca2+ rise by C.STIM1 might reflect any sources of Ca2+ other than plasma membrane C.Orai1 
channels in a heterogeneous cells. I thus performed a definitive test for C. elegans CRAC channel 
activation by conducting whole cell path clamp recordings from HEK 293 cells. I transfected the cells 
with C.STIM1 and either C.Orai1 or H.Orai1 and measured CRAC currents directly. Treatment of these 
cells with EGTA showed the typical CRAC current only when expressing C.STIM1 and C.Orai1 but 
not C.STIM1 and H.Orai1, and the generating Ca2+ current was increased by 10mM Ca2+ application 
and blocked by 10mM LaCl2 while there is no increased current in the cells expressing C.STIM1 and 
H.Orai1 (Figure 1E-F). 
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Also, I next expressed H.STIM1 with either H.Orai1 or C.Orai1 and confirmed that the typical CRAC 
current was shown only in cells expressing H.STIM1 and H.Orai1, but in the cells with H.STIM1 and 




Figure 3. C. elegans has a distinct mode of SOCE. 
 
A) Fura-2 Ca2+ measurements in HEK293 cells expressing C.STIM1 with either C.Orai1 
(blue) or H.Orai1 (red).  
B) Comparison between the SCOE peaks shown in A; ***P < 0.001, unpaired Student’s t 
test; n > 25. 
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C) Fura-2 Ca2+ measurements in HEK293 cells expressing H.STIM1 with either C.Orai1 
(blue) or H.Orai1 (red).  
D) Comparison between the SCOE peaks shown in A; ***P < 0.001, unpaired Student’s t 
test; n > 25. 
E) Time course of ICRAC development in HEK293 cells expressing C.STIM1 with either 
C.Orai1 (blue) or H.Orai1 (red) after whole-cell break-in. 
F) Current–voltage (I–V) relationships from the cells shown in C at peak store-operated 
calcium currents.  
G) Time course of ICRAC development in HEK293 cells expressing H.STIM1 with either 
C.Orai1 (blue) or H.Orai1 (red) after whole-cell break-in. 
H) Current–voltage (I–V) relationships from the cells shown in C at peak store-operated 
calcium currents.  
I) Western blots of whole-cell lysates (Left) or immunoprecipitates (Right) from cells 
expressing C.STIM1 and either C.Orai1 or H.Orai1.  
J) Localization of GFP-C.STIM1 with Cherry-C.Orai1 (Top) or Cherry-H.Orai1 (Bottom).  
K) Localization of GFP-H.STIM1 with Cherry-C.Orai1 (Top) or Cherry-H.Orai1 (Bottom).  
L) Subcellular distribution of GFP-NFAT in HEK293 cells expressing C.STIM1 with 
C.Orai1 or H.Orai1 after store depletion. 
M) Subcellular distribution of GFP-NFAT in HEK293 cells expressing H.STIM1 with 
C.Orai1 or H.Orai1 after store depletion. 
N) NFAT-dependent luciferase activity in cells expressing C.STIM1 and either C.Orai1 or 
H.Orai1. Cells were treated with TG and with PMA. 
O) A schematic drawing of the relationship between C.SOCE and H.SOCE.  
(All scale bars, 10 μm.) The results are typical of at least three independent experiments. 
 
The observation that C.STIM1 activates only C.Orai1, not H.Orai1 led us to test whether this 
difference was due to the different interaction between C.STIM1 and Orai1 channels. I labeled STIM1 
and Orai1 with FLAG and GFP tags, respectively, and then expressed these proteins in HEK 293T cells. 
Immunoprecipitation of Flag-tagged C.STIM1 resulted in coimmunoprecipitation of GFP-tagged 
C.Orai1 only in cells expressing both proteins, but not in cells expressing both C.STIM1 and H.Orai1 
(Figure 1I), indicating that C.STIM1 prefers to bind with C.Orai1 and this interaction might be mediated 
by distinct domain which has different sequences or structural conformation within C.Orai1 compared 
to H.Orai1. 
To further validate the different binding of SOC complex between C. elegans and human in intact 
cells, I investigated the puncta formation of STIM1 and Orai1 by confocal (Figure 1J-K) and TIRF 
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microscope with TG. As previously reported (26, 28, 52, 53), GFP-labeled C.STIM1 showed pre-puncta 
formation but did not form the puncta with cherry-labeled C.Orai1 which localized through the plasma 
membrane before store depletion. The TG treatment showed the clear puncta of GFP-C.STIM1 and 
cherry-C.Orai1 close to the plasma membrane (Figure 1J, top). However, GFP-C.STIM1 did not form 
puncta with cherry-H.Orai1 even after store-depletion with TG (Figure 1J, bottom), indicating that 
C.STIM1 preferentially binds with C.Orai1 in puncta and activates ICRAC of C. elegans after store 
depletion with a distinct mechanism to human SOCE. As expected, GFP-H.STIM1 fails to form puncta 
with cherry-C.Orai1 while it successfully forms puncta with cherry-H.Orai1 with TG stimulation 
(Figure 1K). These results confirmed that STIM proteins prefer to bind and activate Orai proteins among 
different species. 
To test whether C. elegans SOCE developed by C.STIM and C.Orai1 in heterogeneously HEK 293 
cells can induce particular Ca2+ signaling, I introduced GFP-labeled NFAT, a well-known SOC Ca2+ 
responsive transcription factor, into HEK 293 cells. Before store-depletion, 40% of cells have the 
nuclear translocation of GFP-NFAT in the cells expressing C.STIM1 and C.Orai1 compared 5% of cells 
in C.STIM1 and H.Orai1 (Figure 1L). The pre-nuclear localized GFP-NFAT in HEK 293 expressing 
C.STIM1 and C.Orai1 might be caused by leak Ca2+ influx from overexpressed C. elegans SOC 
complex proteins. Moreover, treatment with TG increased 65% of cells expressing C.STIM1 and 
C.Orai1 indicating that store-depletion induced Ca2+ influx by C.SOC complex in heterogeneously HEK 
293 could activate further endogenous Ca2+ signaling to NFAT activation (Figure 1L). While most cells 
expressing H.STIM1 and H.Orai1 showed nuclear translocated GFP-NFAT after store depletion (Figure 
1M). And about less than half of cells expressing either C.STIM1 and H.Orai1 or H.STIM1 and C.Orai1 
have nuclear translocated GFP-NFAT which might be induced by endogenous SOCE with TG treatment, 
indicates that C.STIM1 and C.Orai1 could induce Ca2+ signaling, but they did not interfere with human 
SOC component and its functions. 
Transcriptional gene expression of interleukin 2 (IL2), well-known SOCE responsive gene, is 
known to be induced by nuclear translocation of NFAT. Therefore, to further test whether nuclear 
translocation of NFAT by C. elegans SOCE could induce the expression of its target genes, like IL2, I 
introduced IL2 promoter fused to firefly luciferase reporter plasmid, NFAT-transcriptional reporter, into 
HEK 293T cells. The treatment of TG and PKC activator PMA showed the enhanced firefly luciferase 
activity driven by nuclear translocated NFAT transcriptional activity in the cells expressing both 
C.STIM1 and C.Orai1 (Figure 1N). However, the suppressed NFAT activity in C.STIM1 and H.Orai1 
might be due to H.Orai1 stoichiometry issue with endogenous STIM1 and Orai1. NFAT transcriptional 
activity was clearly enhanced in the cells with H.STIM1 and H.Orai1, but not in the cells with H.STIM1 
and C.Orai1 (Figure 1N).  
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Overall, these results confirmed that C.SOCE could generate Ca2+ signaling pathway even in the 
heterogeneous system but shows a distinct mechanism and led us to make hypothesis that there exist 
different binding or activation mechanisms between C. elegans and human SOCE that differently 
evolved from insects to mammals (Figure 1O). 
 
3.1.2. C. elegans STIM1 shows a minimal activation domain, C.CAD like human STIM1 
CAD 
 
To find the detailed mechanism by which C.STIM1 selectively activates C.Orai1, I first tried to 
map the interaction and regulation domains within C.STIM1 and C.Orai1. I have previously reported 
that STIM1 binds and activates Orai1 directly through the CAD (CRAC channel activation domain) 
within STIM1 during the activation of mammalian SOCE. Thus, to figure out the functional domain 
within C.STIM1 for the activation of C.Orai1, I isolated C. elegans STIM1 CAD (C.CAD, amino acid 
285-388) corresponding human STIM1-CAD and examined whether the C.CAD activated C.Orai1. 
When expressed with C.Orai1 in HEK 293 cells, C.CAD showed elevated Ca2+ rise without depleting 
intracellular stores by TG but fails to activate H.Orai1 (Figure 2A) while H.CAD revealed that it 
activated H.Orai1, not C.Orai1 which is a consistent observation with the function of full-length STIM1 
(Figure 2B).  
This reciprocal activation of C.Orai1 by C.CAD but not H.CAD might be due to different binding 
ability between C.CAD and two Orai1 channels. Thus, I examined whether C.CAD binds to only 
C.Orai1 but not h.Orai1. I labeled C.CAD and Orai1 with FLAG and GFP tags, respectively, and then 
expressed the proteins in HEK 293T cells. Immunoprecipitation of Flag-tagged C.CAD resulted in 
coimmunoprecipitation of GFP-tagged C.Orai1 only in cells expressing both proteins but not H.Orai1 
(Figure 2C), indicating that C.CAD is a potent activator of C.Orai1 channels through direct binding 
which is confirmed by SPR analysis (Figure 2K). 
I further confirmed the binding preference between C.CAD and Orai1 channels by colocalization 
experiment. I first expressed cherry-tagged C.CAD alone or with either C.Orai1 or H.Orai1 in HEK 293 
cells. Like H.CAD, cherry-C.CAD was localized diffusely in the cytoplasm either in the absence of 
C.Orai1 (Figure 2D, Top) or the presence of H.Orai1 (Figure 2D, bottom). However, it moved to the 
plasma membrane when C.Orai1 was expressed (Figure 2D, middle), indicating that C.Orai1 is a 
binding target of C.CAD to form a complex in the plasma membrane. In the case of H.CAD, cherry-
H.CAD was localized to the plasma membrane only in the presence of H.Orai1 (Figure 2E, bottom) but 
it was localized diffusely in the cytoplasm either in the absence of H.Orai1 (Figure 2E, top) or the 








Figure 4. The CRAC CAD of STIM1 binds to the C.Orai1 23L. 
 
A) Fura-2 Ca2+ measurements in HEK293 cells expressing YFP (black), C.CAD and C.Orai1 
(blue), or C.CAD and H.Orai1 (red). The C.CAD-induced constitutive Ca2+ influx was 
measured with 2 mM Ca2+ in the presence of C.Orai1 without store depletion. 
B) Fura-2 Ca2+ measurements in HEK293 cells expressing YFP (black), H.CAD and C.Orai1 
(blue), or H.CAD and H.Orai1 (red).  
C) FLAG-tagged C.CAD coimmunoprecipitated with GFP-C.Orai1 but not with H.Orai1. 
D) Localization of Cherry-C.CAD alone (Top), with C.Orai1 (Middle), and with H.Orai1 
(Bottom). Cherry-C.CAD accumulates at the PM when coexpressed with C.Orai1. 
E) Localization of Cherry-H.CAD alone (Top), with C.Orai1 (Middle), and with H.Orai1 
(Bottom). Cherry-H.CAD accumulates at the PM when coexpressed with H.Orai1. 
F) C.CAD (Top) or H.CAD (Bottom) induced the nuclear translocation of NFAT when it was 
expressed with each pairs (C.CAD with C.Orai1 and H.CAD with H.Orai1) but not when it 
was expressed with other pairs (C.CAD with H.Orai1 and H.CAD with C.Orai1). 
G) NFAT-dependent luciferase activity in cells expressing C.CAD and either C.Orai1 or H.Orai1. 
Cells were treated with PMA or with TG + PMA as indicated.  
H) NFAT-dependent luciferase activity in cells expressing H.CAD and either C.Orai1 or H.Orai1. 
Cells were treated with PMA or with TG + PMA as indicated.  
I) FLAG-tagged C.STIM1 coimmunoprecipitated with the GFP-23L of C.Orai1 but not with the 
NT or CT of C.Orai1. 
J) FLAG-tagged C.CAD coimmunoprecipitated with the GFP-23L of C.Orai1 but not with the 
NT or CT of C.Orai1. 
K) Quantitative SPR measurements of the immobilized GST-23L interacting with various 
concentrations of C.CAD. The Kd value was determined to be 485 nM. 
L) A schematic drawing of the fragments of C.Orai1 23L.  
M) Immunoprecipitation of C.CAD with the M3 domains of C.Orai1. 
N) Fura-2 Ca2+ measurements in HEK293 cells expressing C.STIM1 with either C.Orai1 (blue) or 
C.O_23L-int-H.Orai1 (green). 
O) FLAG-tagged C.STIM1 coimmunoprecipitated with GFP-C.O_23L-int-H.Orai1.  
P) FLAG-tagged C.STIM1 coimmunoprecipitated with GFP-C.Orai1 but not with GFP-C.Orai1 
(ΔM3).  
Q) FRET experiments of C.STIM1-mClover3 with mRuby3-int-C.Orai1.  




An array of experiments was performed to validate C.CAD activity. An elevated Ca2+ driven by C.CAD 
and C.Orai1 in HEK 293 cells resulted in the nuclear localization of GFP-labeled NFAT (Figure 2F), 
and enhanced transcriptional activity of NFAT to IL2 promoter before store depletion (Figure 2H). As 
expected, the nuclear translocation of NFAT by Ca2+ rise and enhanced transcriptional activity of NFAT 
were observed in the cells with H.CAD and H.Orai1 (Figure 2H-I). Both nuclear translocation of NFAT 
and enhanced transcriptional activity of NFAT were not seen either in cells expressing C.CAD and 
H.Orai1 or in the cells expressing H.CAD and C.Orai1 (Figure 2F-I), indicating that C.CAD also has 
the preferential binding ability to Orai1 like full-length C.STIM1. 
 
3.1.3. C.CAD binds to the 2-3 loop of C.Orai1 
 
These results suggest that the reciprocal activation pattern of Orai1 channels by C.CAD might be 
due to the difference in sequences or structural conformation in C.Orai1 channels. Therefore, I tried to 
map the C.CAD target domains within C.Orai1 by immunoprecipitation. I isolated three cytosolic 
domains, the N-terminus (NT, amino acid 1-121), the 2-3 loop (23L, amino acid 170-199), and the C-
terminus (CT, amino acid 249-293) of C.Orai1. And I transiently expressed GFP-tagged N-terminus, 2-
3 loop, and C-terminus of C.Orai1 in HEK 293T cells with Flag-tagged C.STIM1 (Figure 2I) or C.CAD 
(Figure 2J). To my surprise, Flag-tagged C.STIM1 and C.CAD was coimmunoprecipitated with the 2-
3 loop of C.Orai1, not with N-terminus and C-terminus (Figure 2I-J). To check whether the binding of 
C.CAD to 2-3 loop is direct or indirect, I performed SPR experiment with purified recombinant GST-
tagged 2-3 loop and 6xHIS-tagged C.CAD and confirmed the C.CAD binds directly to the 2-3 loop of 
C.Orai1 with a high-affinity KD value of 485 nM (Figure 2K). These results implied that the molecular 
mechanism involved the 2-3 loop of C.Orai1 in C. elegans SOCE could be different and need to be 
explored more because H.STIM1 is known to gate the Orai1 channel through binding both the N-
terminus and the C-terminus of H.Orai1 but not the 2-3 loop. 
To find the interaction domain in more detail, I subdivided the 2-3 loop of C.Orai1 into two 
peptides, M2 peptide (N-half, amino 170-183) and M3 peptide (C-half, amino acid 184-199) (Figure 
2L) and tested which domain was coimmunoprecipitated with Flag-tagged C.CAD. The results showed 
that C.CAD appears to interact with the M3 peptide of the 2-3 loop of C.Orai1 (Figure 2M).  
There has been no report (as far as authors know) that STIM1 binds to the 2-3 loop of Orai1 for the 
activation of SOCE. Thus, this result is quite surprising and novel and let us explore whether M3 peptide 




To further confirm that the M3 domain of C.Orai1 is the minimal activation and binding domain 
of C.STIM1, I performed several experiments. First of all, I checked whether the 2-3loop domain of 
C.Orai1 could recruit C.STIM1. To do that, I made a chimeric H.Orai1 channel (C.O_2-3 loop-int-
H.Orai1) by replacing the 2-3 loop of H.Orai1 to C.Orai1. As in C.Orai1, the chimeric C.O_2-3 loop-
int-H.Orai1 caused Ca2+ influx after treatment with TG by expressed with C.STIM1 in HEK293 cells 
(Figure 2N). Also, I labeled the C.STIM1 with FLAG-tag and Orai1 with GFP-tag, respectively, and 
subsequently performed immunoprecipitation experiments. The result showed that FLAG-tagged 
C.STIM1 binds with the GFP-chimeric Orai1 (Figure 2O). Next, I made the M3 domain deleted C.Orai1 
(C.Orai1-M3). The deleted C.Orai1 (C.Orai1-M3) failed to elevated Ca2+ influx and form the puncta 
with C.STIM1. Also, Flag-tagged C.STIM1 does not coimmunoprecipitated with GFP-tagged C.Orai1-
M3 (Figure 2P). Last, I performed FRET experiments for measured interaction between 2-3 loop and 
STIM1 by using the FRET probe. To do that, I inserted mRuby3 into the 2-3 loop of C.Orai1 at 178 
amino acids (mRuby3-int C.Orai1). The mRuby3-int-C.Orai1 normally induced Ca2+ influx after store 
depletion when expressed with C.STIM1, as in C.Orai1. The result showed that the FRET signal 
increased with after store depletion, means the C.STIM1-mClover3 came close to mRuby3-int-C.Orai1 
(Figure 2Q). Collectively, the results thus far set forth the idea that the 2-3 loop of C.Orai1 is the main 
bona fide binding domain of C.STIM1. 
To date, it is known that STIM1 binds NT and CT of Orai1 channel. Thus, this finding presents a 
non-recognized calcium channel activation mechanism of SOCE in C. elegans. 
 
3.1.4. The M3 peptide of C.Orai1 suppresses SOCE through the interference with the binding 
of C.CAD and C.Orai1. 
 
The finding that M3 peptide within the 2-3 loop of C.Orai1 was shown to bind strongly to C.STIM-
CAD (Figure 2M) led us to check whether M3 peptide could modulate C.SOCE through the competition 
with C.CAD to the 2-3 loop of C.Orai1 as a C.SOCE modulator. 
I first introduced M3 peptide into HEK 293 cells expressing C.STIM1 and C.Orai1 and measured Ca2+ 
rise by Fura-2. The cells showed enhanced SOCE induced by C.STIM1 and C.Orai1 in the absence of 
M3 peptides after store-depletion. However, the cells expressing M3 peptides showed the no further 
Ca2+ rise compared to endogenous SOCE mediated by human STIM1 and Orai1 (Figure 3A-B) 
indicating M3 peptides could suppress C.SOCE through the interference with C.CAD binding to the 2-
3 loop of C.Orai1. 
I further validated whether the decreased Ca2+ rise by the M3 peptide is C.STIM1 and C.Orai1 
dependent or mediated other ion pumps or channels. I conducted whole cell patch clamp recordings to 
measure C.CRAC current directly from HEK 293 cell expressing C.STIM1 and C.Orai1 in the presence 
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or the absence of M3 peptide (Figure 3C-D). Expressing M3 peptide showed the decreased typical 
CRAC current, indicating that the decreased Ca2+ rise by M3 domain was C.SOCE dependent outcome 
and did not interfere with other endogenous Ca2+ channels or pumps. 
Because I could not exclude the possibility that M3 peptide affects other domains of STIM1, and 
first checked that C.CAD is the main binding site for suppressing C.SOCE, I investigated an inhibitory 
effect of the M3 peptide in HEK 293 cells expressing C.CAD and C.Orai1. Expressing M3 peptide 








Figure 5. The 2-3 loop is oligomerization domain of C.Orai1.  
 
A) Fura-2 Ca2+ measurement in HEK 293 cells expressing C.STIM1 and C.Orai1 in the 
absence (blue) or presence of M3 peptide (red). 
B) The histogram shows the SOCE peak shown in Fig. 3A.  
C) Whole cell ICRAC measurements in cells expressing C.STIM1 and C.Orai1 in the absence 
(closed) and the presence of M3 peptide (open). Time course of ICRAC development was 
measured after whole cell break-in. 
D) Current-voltage relationships from the cells expressing C.STIM1 and C.Orai1 (black) and 
together with M3 peptide (red) shown in Fig. 3c at peak currents. 
E) Fura-2 Ca2+ measurements in cells expressing C.CAD and C.Orai1 with (red) or without 
M3 peptide (blue). 
F) The histogram shows that M3 peptide suppressed the elevating intracellular Ca2+ level 
induced by C.CAD. 
G) A graph of plotted points showed the relationship between C.SOCE and C.CAD 
expression in the absence (left) or presence of M3 peptide (right). The x-axis of the scatter 
plot represents the expression level of C.CAD (mean intensity), and the y-axis represents 
an intracellular Ca2+ level. 
H) Nuclear translocation of NFAT was suppressed by expressing of the M3 peptide in cells 
expressing C.Orai1 with C.STIM1. Histograms show that mean of nuclear NFAT. Scale 
bar, 10μm. 
I) Nuclear translocation of NFAT was suppressed by expressing of the M3 peptide in cells 
expressing C.Orai1 with C.CAD. Histograms show that mean of nuclear NFAT. Scale bar, 
10μm. 
J) Cellular localization of cherry-C.STIM1 and GFP-C.Orai1 before and after store depletion 
by TG in the absence (top) or the presence of M3 peptide (bottom). Expression of M3 
peptide inhibited puncta formation of C.STIM1 and C.Orai1. 
K) Cellular localization of GFP-M3 peptide with Cherry-C.STIM1 and Flag-C. after store 
depletion. All images were taken of cell footprint with epi (top) and TIRF microscope 
(bottom). Scale bar, 10μm. 
L) Cellular localization of GFP-M3 peptide with Cherry-C.Orai1 and Flag-C.STIM1 after 
store depletion. All images were taken of cell footprint with epi (top) and TIRF microscope 
(bottom). Scale bar, 10μm. 
M) Immunoprecipitation of Flag-tagged C.Orai1 with GFP-tagged cytosolic domains of 
C.Orai1. 
N) Immunoprecipitation of the Flag-tagged 2-3 loop with GFP-tagged cytosolic domains of 
C.Orai1. The 2-3 loop of C.Orai1 coimmunoprecipitated with GFP-tagged 2-3 loop, but 
32 
 
very weakly with the N-terminus of C.Orai1, indicating the 2-3 loop appears to be 
oligomerization domain. 
O) M3 peptide coimmunoprecipitated with GFP-tagged M3 peptide, indicating M3 peptide 
is a minimal dimerization domain. 
 
I checked whether the suppressed Ca2+ rise was due to the reduced C.CAD expression level when 
I co-expressed M3 peptides. I plotted a Ca2+ rise over the C.CAD expression level by cherry 
fluorescence measurement. The inhibitory effect of the M3 peptide on C.CAD activity was not due to 
C.CAD expression level. Because most cells coexpressing C.CAD and M3 peptides did not increase 
Ca2+ rise even in higher expression intensity od C.CAD (Figure 3G, right) compared to the activity of 
C.CAD in the absence of M3 peptide (Figure 3G, left). This result implied that M3 peptides seem potent 
SOCE modulator in C. elegans. 
Next, I checked whether M3 peptide could suppress nuclear translocation of NFAT induced by 
SOCE. The population of nuclear translocation of NFAT in HEK 293 cells expressing the M3 peptide 
with C.STIM1 and C.Orai1 was reduced from 90% to 50% after store depletion (Figure 3H) which is 
similar induced by endogenous SOCE, indicating that M3 peptide binds and suppresses C.SOCE but 
not endogenous SOCE. Again, the population of nuclear translocation of NFAT in cells expressing 
C.CAD and C.Orai1 was 65% and was decreased to 20% when the M3 peptide was expressed (Figure 
3I). 
To verify how M3 peptide suppressed C.STIM1 on C.SOCE, I first checked whether M3 peptide 
could interfere with the binding of C.STIM1 to C.Orai1 by examining puncta formation. I expressed 
Flag-tagged M3 peptide into HEK 293 cells expressing cherry-labeled C.STIM1 and GFP-labeled 
C.Orai1 and induced store-depletion by TG. I observed that most cherry-C.STIM1 did not form a puncta 
with GFP-C.Orai1. (Figure 3J). This result confirmed that M3 peptide suppressed C.SOCE through the 
C.STIM1 and C.CAD via direct and competitive binding. 
Next, I further clarify that C.STIM1 is the target proteins of the M3 peptide, I expressed GFP-
labeled M3 peptides with cherry-labeled STIM1 and Flag-tagged C.Orai1 in HEK 293 cells (Figure 
3K). And I could observe GFP-M3 peptides localized to cherry-C.STIM1 in the puncta. However, some 
puncta of GFP-M3 peptide did not colocalize with cherry-C.STIM1, indicating that M3 peptide might 
have other target proteins to form puncta. Therefore, I tested whether M3 peptide bind to C.Orai1 as 
well (Figure 3L). I expressed cherry-C.Orai1 with GFP-M3 peptide and Flag-tagged C.STIM1 in cells. 
Interestingly, the GFP-M3 peptide was localized to Cherry-C.Orai1 clearly in puncta. These results 
show that M3 peptide could bind both C.STIM1 and C.Orai1, indicating that M3 peptide has an 
unexpected mechanism by which M3 peptides suppress C.SOCE. 
These results suggest that C.Orai1 might form the dimer via the 2-3 loop interaction of each 
C.Orai1 and it was surprised and unexpected because mammalian Orai1 is known to form a dimer 
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through its C-terminus of Orai1 proteins in an anti-parallel orientation. Thus, this finding led us test 
whether M3 peptides could bind to full-length and cytosolic domains of C.Orai1. First, I expressed 
Flag-tagged Orai1 with each GFP-labeled cytosolic domains, the N-terminus, the 2-3 loop, and the C-
terminus of C.Orai1 and immunoprecipitation of C.Orai1 resulted in coimmunoprecipitation of the 2-3 
loop of C.Orai1 (Figure 3M), indicating that the 2-3 loop of C.Orai1 might function as dimerization 
domain. Next, I expressed Flag-tagged 2-3 loop with GFP-labelled cytosolic domains and 
immunoprecipitation of the 2-3 loop resulted in coimmunoprecipitation of the 2-3 loop but weak 
interaction with N-terminus, indicating that the 2-3 loop of C.Orai1 was sufficient to form a dimer or 
higher complex (Figure 3N). 
To map more potential dimer domain within the 2-3 loop of C.Orai1, I used M3 peptide because 
M3 peptide was functionally important and was a target domain of C.CAD (Figure 2J-M). I expressed 
Flag-tagged M3 with either GFP-labelled 2-3 loop, M2 peptide and M3 peptide, and 
immunoprecipitation of the M3 peptide resulted in coimmunoprecipitation of M3 domain with a higher 
affinity (Figure 3O). These results showing that M3 peptide also was able to bind full-length of C.Orai1 
and confirmed that M3 peptide region in the 2-3 loop is dimerization domain of C.Orai1. 
 
3.1.5. Mutation at FY of 2-3 Loop produces constitutive active C.Orai1 channel 
 
Several lines of evidence indicated that the 2-3 loop of C.Orai1 is a critical domain for the binding 
and the function of both C.STIM1 and C.Orai1. To validate which amino acids are necessary for the 
role of the 2-3 loop during the C.SOCE activation, I aligned and compared with the amino acid 
sequences of the 2-3 loop of Orai1 isoforms from representative species ranging from invertebrates, C. 
elegans to vertebrates, human (Figure 4A). Interestingly, I found that two hydrophobic amino acids 
within M3 domain of C. elegans Orai1 are conserved in among invertebrates while these corresponding 
amino acids were positive charged amino acids (R170, H171) in human Orai1, and these are well 
conserved among vertebrates. (Figure 4A), indicating that these hydrophobic amino acids (FY) might 
play a conserved role in the function of Orai1 of C. elegans and other invertebrates and explain the 
different regulation mechanism between C. elegans and human or invertebrates and vertebrates, evolved 
differently and need to be studied. 
To check whether these conserved amino acids are essential for the function of C.Orai1, I converted 
two conserved amino acids (FY) of C.Orai1 to the positively charged amino acids (RH) of vertebrates 
to generate mutant C.Orai1 (FY-RH) and mutant M3 peptide (FY-RH). I first tested whether mutations 
abolished the oligomerization of M3 peptide or C.Orai1 (Figure 3M-O). Immunoprecipitation of the 
M3 peptide (FY-RH) resulted in coimmunoprecipitation of M3 peptide (FY-RH) only but not wild-type 
M3 peptide (Figure 4B-C). This result led us to check whether the mutation could affect the function of 
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C.Orai1 (FY-RH) compared to wild-type C.Orai, I first measured intracellular Ca2+ rise by Fura-2 in the 
absence of STIM1. I expressed either wild-type or mutant C.Orai1 (FY-RH) in HEK 293 cells without 
expressing C.STIM1. To my surprise, the cells expressing C.Orai1 (FY-RH) showed constitutive Ca2+ 
influx even before store-depletion while wild-type C.Orai1 alone has no effect on C.SOCE compared 
to endogenous SOCE (Figure 4D). Next, I checked whether this Ca2+ rise is dependent on C.Orai1 (FY-
RH) by whole cell patch clamp, and confirmed constitutive Ca2+ current evoked by C.Orai1 (FY-RH) 
without C.STIM1 or store depletion (Figure 4E-F). Converting two conserved amino acids to polar 





Figure 6. The FY-RH mutation in the 2-3loop produces a constitutively active C.Orai1 channel. 
 
A) Sequence alignment of the 23L of Orai1 channels from C. elegans to human, showing 
identical or conserved amino acids (black) and non-conserved amino acids (gray). The 
conserved amino acids essential for this study in invertebrates and vertebrates are shown in 
bold red and blue fonts, respectively. 
B) FLAG-tagged C.Orai1 (FY-RH) coimmunoprecipitated with GFP-tagged C.Orai1 (FY-RH) 
but not with WT C.Orai1. 
C) The FLAGtagged M3 peptide (FY-RH) coimmunoprecipitated with the GFP-tagged M3 
peptide (FY-RH) but not the WT M3 peptide of C.Orai1. 
D) Fura-2 Ca2+ measurements in HEK293 cells expressing YFP (black), C.Orai1 (blue), or 
C.Orai1 (FY-RH) (red).  
E) Whole-cell ICRAC measurements on HEK293 cells expressing C.Orai1 (blue) or C.Orai1 
(FY-RH) (red). The time course of ICRAC development was measured after whole-cell 
break-in.  
F) I–V relationships from the cells expressing C.Orai1 (blue) or C.Orai1 (FY-RH) (red) shown 
in C at peak store-operated currents in 10 mM Ca2+ Ringer’s solution. 
G) Cellular localization of Cherry-C.Orai1, C.Orai1 (FY-RH), or H.Orai1 (V102C). C.Orai1 
(FY-RH) alone made prepuncta without C.STIM1. 
H) Cellular distribution of GFP-NFAT in HEK293 cells expressing C.Orai1 or C.Orai1 (FY-RH) 
alone. GFP-NFAT translocated into the nucleus in the cells expressing C.Orai1 (FY-RH) 
even before store depletion by TG. 
I) Histograms showing the mean abundance of nuclear-translocated NFAT under the indicated 
conditions. 
J) A graph showing the relationship between the proportion of nuclear-translocated NFAT and 
the expression level of C.Orai1 in the absence of C.STIM1. The x axis of the scatter plot 
represents the expression level of C.Orai1 (mean fluorescence intensity), and the y axis 
represents the subcellular localization of NFAT in either the cytosol (Cyto) or the nucleus 
(Nu).  
K) Time course of FRAP from single cells expressing C.Orai1 or C.Orai1 (FY-RH). 
L) Mobile fractions of GFP-C.Orai1 or C.Orai1 (FY-RH) alone; data are shown as means ± SE; 
n > 13.  
M) Fura-2 Ca2+ measurements in STIM1-KO U2OS cells expressing YFP (control, black), 
C.Orai1 (blue), or C.Orai1 (FY-RH) (red). 




As far as I know, there is no report about cytosolic domain induced Orai1 oligomerization and 
leaky gating as most studies are from pore-lining mutations to make channel constitutively active. 
Therefore I explored by which C.Orai1 (FY-RH) induces intracellular Ca2+ rise even without C.STIM1. 
First, I expressed cherry-labeled C.Orai1 or C.Orai1 (FY-RH) alone in HEK 293 cells and checked the 
expression pattern of C.Orai1 channels close to the plasma membrane by TIRF microscope. While wild-
type C.Orai1 was distributed evenly in the plasma membrane, C.Orai1 (FY-RH) showed to form puncta 
before store depletion or in the absence of C.STIM1 (Figure 4G), indicating that C.Orai1 (FY-RH) itself 
could increase cytosolic Ca2+ directly from C.Orai1 (FY-RH) puncta complex through the 2-3 loop 
oligomerization. I next checked whether C.Orai1 (FY-RH) itself would activate SOCE downstream 
signaling cascade, e.g., nuclear localization of cytosolic NFAT. 
When I introduced GFP-NFAT in the cells expressing C.Orai1 (FY-RH), 70% of the cells showed 
nuclear translocation of NFAT before store depletion, and its proportion was further increased to 90% 
with store depletion by TG (Figure 4H-I). 
To validate how potent C.Orai1 (FY-RH) is, I compared the expression level of cherry-labeled 
C.Orai1 (WT) or C.Orai1 (FY-RH) to the proportion of nuclear localized NFAT. While the cells with 
higher expression of C.Orai1 (wild type) alone did not show nuclear translocation of NFAT, most cells 
with C.Orai1 (FY-RH) expression showed the nuclear translocation of NFAT regardless of C.Orai1 (FY-
RH) expression level (Figure 4J). And these results clearly indicated that C.Orai1 (FY-RH) is a potent 
and constitutively active channel subunit that can form SOCE complex even in the absence of C.STIM1. 
Fluorescence recovery after photobleaching (FRAP) experiments is used to measure the complexity of 
C.Orai1 and C.Orai1 (FY-RH). I expressed either wild-type C.Orai1 or C.Orai1 (FY-RH) alone and 
measured the mobile fraction by conducting FRAP in HEK 293 cells. My FRAP measurements of GFP-
C.Orai1 alone in HEK 293 cells suggest that a mobile fraction of 56.5 ± 4.9% are mobile in the 
membrane, demonstrating that C.Orai1 channels are freely diffusible and quite mobile in the plasma 
membrane (Figure 4K-L). In the cells expressing GFP-C.Orai1 (FY-RH) the mobile fraction was less 
(11.8 ± 5.4%), and C.Orai1 (FY-RH) diffusion was more slowed by a factor of five (Figure 4K-L). Thus, 
the significant slowing of C.Orai1 (FY-RH) diffusion is consistent with puncta and constitutively active 
channel formation.  
Furthermore, I performed Ca2+ imaging in STIM1-KO U2OS cells with introduce C.Orai1 
(FY-RH) mutant to remove the effect of endogenous STIM proteins. As expected, C.Orai1 (FY-RH) 
induced a constitutive Ca2+ rise even before store depletion in the STIM1-KO U2OS cells (Figure 4M). 
Overall, the molecular mechanism by which C.STIM1 regulates C.Orai1 requires further studies, but 




3.1.6. Constitutive permeant C.Orai1 (FY-RH) is regulated by C.STIM1 binding  
 
Several reports showed that outward current was measured from constitutively active Orai1 
bearing pore-lining residue mutation (human Orai1 F99C, V102C) in the absence of STIM1 (54, 55). 
However, an outward current was not measured from the cells expressing C.Orai1 (FY-RH) in the 
absence of STIM1 (Figure 4E). I checked whether C.STIM1 regulated inward current and gating 
property of constitutively active C.Orai1 (FY-RH) channels, I expressed C.STIM1 and C.Orai1 (FY-
RH) in HEK 293 cells and measured Ca2+ current in the cells by whole-cell patch clamping. The results 
showed that the inward current was blocked by C.STIM1 expression (Figure 5A) compared to a leaky 
inward current in the absence of C.STIM1 (Figure 5A-B). There was no difference in Ca2+ gating and 
permeability of C.Orai1 (FY-RH) when expressing C.STIM1 compared to that of wild-type C.Orai1 
and C.STIM1 (Figure 5A-B), indicating a leaky gate of C.Orai1 (FY-RH) could be regulated by 
C.STIM1 or C.CAD. This observation led us to check the binding and localization of both proteins. 
First, I checked whether C.STIM1 interacted with C.Orai1 (FY-RH) by TIRF microscope. HEK 293 
cells expressing cherry labeled C.STIM1 and GFP-labeled C.Orai1 (FY-RH) showed pre-puncta before 
store depletion (Figure 5C), indicating the constitutively active C.Orai1 (FY-RH) channel could be 
regulated by bound C.STIM1 directly. I next checked the interaction by immunoprecipitation. I 
expressed Flag-tagged C.CAD with GFP-labeled Orai1 or Orai1 (FY-RH), and immunoprecipitation of 







Figure 7. Gating of the C.Orai1 (FY-RH) channel is regulated by C.STIM1 binding. 
 
A) The time course of ICRAC development in cells expressing C.STIM1 with either C.Orai1 
(blue) or C.Orai1 (FY-RH) (red) after whole-cell break-in. The Ca2+ permeability of the 
C.Orai1 (FY-RH) channel is regulated by C.STIM1 binding. 
B) I–V relationships in the cells expressing C.STIM1 and either C.Orai1 (blue) or C.Orai1 (FY-
RH) (red) shown in A at peak store-operated currents in 10 mM Ca2+ Ringer’s solution.  
C) Cellular localization of Cherry-C.STIM1 and GFP-C.Orai1 (FY-RH) before store depletion. 
C.Orai1 (FY-RH) formed prepuncta with C.STIM1. All images of the cell footprint were 
taken with epifluorescence and TIRF microscopes. (Scale bar, 10 μm.) 
D) FLAGtagged C.CAD coimmunoprecipitated with both GFP-tagged C.Orai1 and C.Orai1 
(FY-RH) showing that C.Orai1 (FY-RH) can be regulated by C.STIM1 or C.CAD binding. 
E) Time course of FRAP from single cells expressing C.STIM1 with C.Orai1 or C.Orai1 (FY-
RH). 





FRAP was performed to check whether clustering C.STIM1 with C.Orai1 (FY-RH) affect the 
complexity in intact cells, I expressed C.STIM1 with GFP-C.Orai1 or C.Orai1 (FY-RH) in HEK 293 
cells. My FRAP measurements of the C.STIM1 and GFP-C.Orai1 in HEK 293 cells before store-
depletion showed that a mobile fraction of 31.5 ± 3.2% are mobile in the membrane, demonstrating that 
C.Orai1 channels are freely diffusible and quite mobile in the plasma membrane before store-depletion. 
And the mobility of C.Orai1 was slowed to 18.4 ± 0.9% with TG treatment, indicating C.Orai1 was 
bound with C.STIM1. (Figure 5E-F). 
However, a mobile fraction of 3.4 ± 1.3% is mobile in the membrane regardless of store depletion 
(Figure 5E-F) in HEK 293 cells co-expressing GFP-C.Orai1 (FY-RH) and C.STIM1, indicating that 
Orai1 (FY-RH) and C.STIM1 were able to cluster in the cell membrane, but bound C.STIM1 altered 
ion permeability of C.Orai1 (FY-RH). 
These results imply that C.STIM1-CAD binding to the 2-3 loop of C.Orai1 (FY-RH) changed the 
conformational alignment of ion selective filters in C.SOC complex, leading to being closed or 
intermediate state and confirmed that binding and activation of C.SOC complex is a separate step in C. 





3.1.7. SOCE is orchestrated through an interaction between N-terminus and the 2-3 loop of 





Figure 8. C.SOCE is orchestrated through the interaction between the NT and the 2-3 loop of C.Orai1. 
 
A) FLAG-tagged C.Orai1 NT and CT coimmunoprecipitated with the GFP-23L.  
B) FLAG-tagged C.Orai1 NT and CT coimmunoprecipitated with the GFP-23L.  
C) FLAG-tagged NT and CT coimmunoprecipitated with the GFP-23L but not with the 23L (FY-
RH). 
D) FLAG-tagged NT and CT coimmunoprecipitated with the GFP-23L but not with the 23L (FY-
RH).  
E) The predicted 3D structure of the C.Orai1 monomer between 40–50 ns of MD simulation. 
F) The predicted rmsd of the C.Orai1 monomer between 40–50 ns of MD simulation. 
G) The RMSF probability analysis of the C.Orai1 monomer between 40–50 ns of MD simulation.  
H) Western blots of whole-cell lysates from the cells expressing cpVenus-C.Orai1 and cpVenus-
C.Orai1 (FY-RH). 
I) Nuclear translocation of GFP-NFAT in cells expressing cpVenus-C.Orai1 alone (Left) or 
together with C.CAD (Middle) or cpVenus-C.Orai1 (FY-RH) alone (Right). 
J) Histograms show the mean abundance of nuclear-translocated NFAT under the indicated 
conditions. 
K) Representative images of cpVenus fluorescence in HEK293 cells expressing cpVenus-C.Orai1 
(Upper) and cpVenus-C.Orai1 (FY-RH) (Lower). PM-localized Lyn-Cherry was visualized on 
the same focus plane. 
L) Mean fluorescence intensity of cpVenus-C.Orai1 and cpVenus-C.Orai1 (FY-RH). 
M) A schematic representation depicting the mechanism by which cpVenus fluorescence is altered 
by the conformational change of C.Orai1. 
N) Representative images of cpVenus-C.Orai1 before and after store depletion. 
O) The time course of the fluorescence intensity of cpVenus-C.Orai1 in cells expressing Cherry-
C.STIM1. Store depletion by TG increases the fluorescent intensity of cpVenus-C.Orai1 only 
in the presence of C.STIM1. 
P) FRET experiments of mRuby3-C.Orai1-mClover3 with or without C.STIM1 and C.Orai1-
mRuby3 with C.STIM1-mClover3. (All scale bars, 10 μm.) 
 
Unlike the proposed gating mechanism of mammalian Orai1 channels by its intracellular N- and 
C-terminus, C. elegans Orai1 shows a different but unexplored gating mechanism regulated by the 2-3 
loop of C.Orai1 channels. However, the molecular mechanism by which the 2-3 loop of C.Orai1 
orchestrates C.SOCE remains elusive. 
42 
 
I first checked whether the 2-3 loop of C.Orai1 could be accessed by other cytosolic domains of 
C.Orai1 as a part of gating mechanism, because the 2-3 loop is the common binding domain of STIM1, 
CAD and the 2-3 loop for oligomerization. Immunoprecipitation results showed that N-terminus and 
C-terminus could bind to wild-type 2-3 loop, but not to mutated 2-3 loop (FY-RH) of C.Orai1 (Figure 
6A-D), indicating that the 2-3 loop of closed channel is bound by other cytosolic domains, but the 2-3 
loop of constitutively open channel is unbound. This binding preference led us to propose the 
intramolecular switch model that the gating of Orai1 channels is regulated by the intramolecular 
interaction between cytosolic domains of C.Orai1. To understand the gating mechanism of C. elegans 
SOC channels in detail, I assumed that there is a different conformational structure or more flexible 
domains between the closed and open state of C.Orai1. Therefore, I applied MD simulations using 
models constructed predicted C.Orai1 monomer block modified from the crystal structure of the 
Drosophila Orai1 (PDB: 4HKR). Simulation system reached a steady state after 40 ns (Figure 6E-G). I 
measured and compared structural fluctuation pattern. The root-mean-squared fluctuation (RMSF) 
results showed that there were high fluctuations in the N- and C-terminus, but not in other domains of 
C.Orai1 (Figure 6G). And RMSF plot of N-terminus showed that there were two fluctuation portions, 
distal N-terminus of C.Orai1 (amino acid 1 to 64) and proximal N-terminus (amino acid 65 to 121) 
(Figure 6G). I designed circularly permutation Venus (cpVenus) fluorescent protein, which is sensitive 
to pH or conformational change (56-58). Then I generated cpVenus-C.Orai1 by inserting cpVenus in 
between two fluctuation portions, amino acid A64 and G65 in N-terminus of C.Orai1, and expected the 
change in cpVenus fluorescence between different states of Orai1 channels (Figure 6M). 
I expressed cpVenus-C.Orai1 or cpVenus-C.Orai1 (FY-RH) in HEK 293 cells, and measured the 
expression level of these proteins by Western blot. I could see the similar expression level of both 
proteins (Figure 6H). And cpVenus-C.Orai1 channels are fully functional because most cells expressing 
cpVenus-C.Orai1 with C.CAD showed elevated nuclear localization of NFAT (Figure 6I-J) before store 
depletion. And the cells with cpVenus-C.Orai1 (FY-RH) alone showed elevated nuclear localization of 
NFAT, indicating that adding cpVenus in the N-terminus of C.Orai1 did not change its wild-type or 
constitutively active function. To check whether the N-terminal fluctuation changed the fluorescence of 
cpVenus, I expressed either cpVenus-C.Orai1 or cpVenus-C.Orai1 (FY-RH) with Lyn-cherry as a plasma 
membrane marker in HEK 293 cells, and measured the fluorescent intensity with TG treatment using 
TIRF microscope. Interestingly, most cells expressing cpVenus-C.Orai1 (FY-RH) showed strong 
fluorescent intensity before store depletion but did not increase after TG treatment. However, most cells 
expressing cpVenus-C.Orai1 showed weak fluorescent intensity regardless store depletion (Figure 6K-
L). However, these difference in fluorescent intensity at rest was not due to the expression level or 
channel function as seen in Figure 6H. Therefore, the different fluorescent intensity of between 
cpVenus-C.Orai1 and cpVenus-C.Orai1 (FY-RH) could be from various state of C.Orai1, closed and 
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open state. Thus, I next expressed cpVenus-C.Orai1 with cherry-C.STIM1 in HEK 293 cells, and 
measured cpVenus fluorescent intensity with TG treatment. To my surprise, cpVenus-C.Orai1 clearly 
showed the increasing cpVenus fluorescent intensity and formed co-puncta with cherry-C.STIM1 after 
store depletion (Figure 6N-O). 
Next I measured the FRET signals by using FRET probes (mRuby3-C.Orai1-mClover3, C.Orai1-
mRuby3 and C.STIM1-mClover3) for detected the intramolecular interaction between C.STIM1 and 
C.Orai1. The open circles, the cells which expressed mRuby3-C.Orai1-mClover3 with C.STIM1 
showed decreased signal of FRET after store depletion (Figure 6P, open circles). While, the close circles, 
the cells without C.STIM1 showed no decrease of FRET signal even after store depletion (Figure 6P, 
close circles). These results mean that C.Orai1 showed FRET signal at the closed state by the NT and 
CT of C.Orai1 were close enough and then displaced to decreased FRET signal, after store depletion to 
form open state. 
Together, these results implied that N-terminus of C.Orai1 changed its orientation from inward, 
close to the 2-3 loop to outward facing when C.STIM1-CAD approaches by store depletion, and this 
motion might affect the fluorescence of cpVenus. While N-terminus of constitutively active C.Orai1 
(FY-RH) already present outward facing, therefore developed fluorescent intensity was not changed. 
Previously, there have been many reports to show the bimolecular interaction of Orai1 and STIM1 using 
BiFC or FRET, but as far as I know, my result was first to approach to visualize the motion of 
intracellular domain of Orai1 channel during the gating process of Orai1 channels in vivo.   
 
3.1.8. Intramolecular switch is arranged through the hydrophobic interaction between both 
distal N-terminus, C-terminus and the 2-3 loop of C.Orai1 in C. elegans 
 
The data indicated that the CT of C.Orai1 also seemed to be involved in the interaction with the 2-
3 loop of C.Orai1 (Figure 6B). However, I failed to the supposed interacting domain in the CT of 
C.Orai1. 
We have shown that both NT and CT bind to the 23L at rest (Figure 6A-D) and induce the 
conformational change after the store depletion (Figure 6M). And we made the NT and/or the CT 
truncated Orai1 channels (NT, CT). However, these truncated C.Orai1 channels were not activated 
by C.STIM1 and did not form the puncta with C.STIM1, indicating that other cytosolic domains are 
also essential for the function of C.Orai1. 
We next asked which portions of NT and CT of C.Orai1 are responsible for the conformational 
change related to the binding of the 23L. In parallel with the molecular dynamics simulation showing 
high fluctuations in the NT and CT (Figure 6E-G). We made cpVenus-65-C.Orai1 channels in which 
the N-terminal 64 amino acids (amino acids 1–64) were deleted and measured intracellular Ca2+ rises 
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in cells with 65-C.Orai1. We expressed either wild-type or 65-C.Orai1 in HEK 293 cells with 
C.STIM1. As we expected, both cells expressing either wild-type or 65-C.Orai1 showed basal Ca2+ 
level before store depletion and showed an elevated Ca2+ influx after store depletion (Figure 7A). We 
next checked the function of the cpVenus-65-C.Orai1 channels by measuring the nuclear translocation 
of GFP-NFAT. We expressed cpVenus-65-C.Orai1 with or without C.CAD in HEK 293 cells. Like the 
cells expressing the full-length cpVenus-Orai1, those expressing cpVenus-65-C.Orai1 alone did not 
show any NFAT nuclear translocation, but the cells expressing cpVenus-65-C.Orai1 with C.CAD 
showed an elevated abundance of nuclear-localized NFAT (Figure 7B-C). And we measured the 
fluorescence intensity of cpVenus by expressing either cpVenus-C.Orai1 or cpVenus-65-C.Orai1 alone 
in HEK 293 cells by TIRF microscopy. To my surprise, cpVenus-65-C.Orai1 showed a strong 
fluorescence intensity and was localized diffusely in the PM even before store depletion in the absence 
of C.STIM1 (Figure 7D-E), while full-length cpVenus-C.Orai1 did not show fluorescence at rest as 
shown in Figure. 6K. These results indicate that the deletion of distal N-terminal 64 amino acids did not 
affect the function and the closed conformation of 65-C.Orai1 maintained by other intramolecular 
interactions between the 23L and the proximal NT and the CT (Figure 7F), and its gating is still required 
C.STIM1 binding to develop C.SOCE and regulated by the other portion of NT and the CT. (Figure 
7H).  
To check whether the CT is responsible for the conformational change related to the binding of the 
23L and the gating of C.Orai1, we made several mutant C.Orai1 channels (V271 and M274, equivalent 
residues in H.Orai1 L273, L276). The immunoprecipitation of FLAG-tagged C.STIM1 resulted in the 
co-immunoprecipitation of all CT mutant C.Orai1 channels but failed to result in calcium influx when 
expressed with C.Orai1 (Figure 7G), indicating that the gating of C.Orai1 is still required the functional 
conformation of the CT and the displacement of NT and CT from the 23L by C.STIM1 binding or store 
depletion. 
Taken together, these results implied that the NT and the CT of C. Orai1 binds to the 23L of the 
channel forming a ‘closed channel’ in the resting state, while it undergoes a conformational change into 





Figure 9. C.SOCE is regulated by the hydrophobic interaction between the NT and the 2-3 loop of 
C.Orai1. 
 
A) Fura-2 Ca2+ measurements in HEK293 cells expressing YFP (black), C.STIM1 and C.Orai1 
(blue), or C.STIM1 and Δ64-C.Orai1 (green). 
B) Nuclear translocation of GFP-NFAT in cells expressing Δ64-C.Orai1 either alone (Left) or 
together with C.CAD (Right). 
C) Histograms showing the mean abundance of nuclear-translocated NFAT under the indicated 
conditions. 
D) Representative images of cpVenus fluorescence in HEK293 cells expressing cpVenus-
C.Orai1 or cpVenus-Δ64-C.Orai1. 




F) A schematic depicting the mechanism by which the deletion of the distal NT of C.Orai1 
recovers the fluorescence of cpVenus-Δ64-C.Orai1 but the proximal NT and CT still 
maintain the closed form of C.Orai1. 
G) Fura-2 Ca2+ measurements in HEK293 cells expressing C.STIM1 with C.Orai1 (blue), 
C.Orai1 (V271S) (orange), or C.Orai1 (M274S) (green). 




3.2. Orai1 inhibitor STIM2 regulates myogenesis by controlling SOCE dependent 
transcriptional factors. 
 
3.2.1. Role of STIM2 in muscle development. 
 
We first examined the function of STIM2 on the skeletal muscle differentiation by investigating 
the expression pattern of STIM2 splicing changes during the C2C12 myoblast cells differentiation. 
Relative quantitative RT-PCR analysis showed that STIM2 expression level was gradually increased 
after inducing differentiation in C2C12 myoblast cells (Figure 8A-C). This data means that through this 
dramatic change of splicing pattern, myoblast cells can efficiently regulate a dynamic period of Ca2+ 
signaling during myogenesis.  
Furthermore, when we knockdown STIM2 and induce differentiation for 2days, the expression 
of myogenic genes was strongly inhibited. When knockdown STIM2 gene, the myogenin expression 
was decreased by 40% and -MHC was decreased by more than 50% (Figure 8D-H). To further validate 
the function of STIM2 in myogenesis, I investigated the population of myogenin-positive cells at day 
2 after inducing differentiation following transfection of sh-Scr or sh-STIM2. Surprisingly, less than 
10% of the sh-STIM2-treated cells had myogenin- and MHC-positive nuclei, respectively, whereas 
close to 20% of the sh-Scr-treated cells were positive for these markers (Figure 8I-L). These results 
indicated that transient knockdown of STIM2 suppressed the expression of myogenic genes during 
C2C12 myogenesis. 
Collectively, these experiments indicated that STIM2, which a novel splicing variant of a STIM2 
gene, was up-regulated during muscle differentiation and through this novel splicing pattern of a STIM2 
gene, C2C12 myoblast cells efficiently control the skeletal muscle differentiation. However, due to the 










Figure 10. STIM2 splicing affects myogenesis. 
 
A) Expression of STIM2 splicing variants during the differentiation of C2C12 myoblast cells. 
B) GAPDH-normalized expression levels of STIM2β during C2C12 myoblasts differentiation. 
C) Histogram of the STIM2α/STIM2β ratio during C2C12 differentiation. 
D) Polymerase chain reaction analysis of cDNA from Control (sh-Scr) and STIM2β knock-down 
(sh-STIM2β) cells 2 day after inducing differentiation. 
E) GAPDH-normalized expression levels of STIM2α. 
F) GAPDH-normalized expression levels of STIM2β.  
G) GAPDH-normalized expression levels of myogenin.  
H) GAPDH-normalized expression levels of MHC. 
I) The ICC of myogenin positive cells from control cells (I, Top) and STIM2β knock-down cells 
(I, Bottom). 
J) The fraction of myogenin positive cells from control cells and STIM2β knock-down cells (J, 
white bar). (n > 80 cells for each group). 
K) The ICC of MHC positive cells from control cells (K, Top) and STIM2β knock-down cells (K, 
Bottom). 
L) The fraction of MHC positive cells from control cells (L, black bar) and STIM2β knock-down 
cells (L, white bar). (n > 80 cells for each group).  
Error bars show means ± SEM. (All scale bars, 20 μm.) The results are representative of at 
least three independent experiments. 
 
3.2.2. Generation of STIM2 knockout cell line. 
 
To further validate the function of STIM2 on the skeletal muscle differentiation, we generate the 
STIM2 knockout C2C12 myoblast cell line by using the CRISPR-Cas9 gene editing system. To do 
that, we design sgRNA for target Exon9 region which only included in STIM2 . We observed the 
evident decreased length of PCR products and confirmed the 226nt deletion around Exon9 region by 
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sequencing. To test whether this CRISPR/Cas9 mediated deletion successfully knockout STIM2 gene, 
we check the expression level of STIM2 splicing variants, STIM2 and STIM2 after inducing C2C12 
myoblast differentiation. While C2C12 myoblast cells showed up-regulation of STIM2 during 
myogenesis, the expression of the STIM2 gene was abolished in the STIM2 knockout cell line. Also, 
STIM2 knockout cells normally express another STIM2 splicing form, STIM2, after inducing 
C2C12 myoblast differentiation. 
These results indicated that CRISPR-Cas9 mediated 226nt deletion at exon9 region only abolished 
STIM2 gene and did not affect the expression of STIM2 genes. 
 
3.2.3. STIM2 knockout inhibit muscle differentiation. 
 
We next examined whether STIM2 knockout affects the C2C12 myoblast differentiation. To do 
that, we measured the mRNA expression of myogenic marker genes in both wild-type and STIM2 
knockout cells. Interestingly, the GAPDH normalized expression level of both myogenin and -MHC 
was significantly decreased in STIM2 knockout cells (Figure 9A–C). The GAPDH normalized 
expression level of myogenin was gradually decreased after 1.5days and -MHC expression of STIM2 
knockout cells showed only half of the wild-type cells on 2.5 days after inducing differentiation. 
  In addition to the decreased expression of the myogenin and -MHC mRNA, western blot 
experiment indicates that STIM2 knockout cells showed significantly decreased protein expression of 
myogenin and -MHC than wildtype C2C12 cells. In wild-type myoblast cells, myogenin expressed 
since 1day after inducing differentiation and -MHC expressed since 2days. Compared, myogenin of 
STIM2 knockout cells start detected very weakly after 2days. Also, -MHC protein was detected from 
3days after inducing differentiation (Figure 9D-F). Finally, Immunofluorescence staining data showed 
that both myogenin (Figure 9G, H) and -MHC (Figure 9I, J) positive nuclei portion decreased by half 
in STIM2 knockout cells compared with wild-type cells. 
We next questioned whether inhibition of C2C12 myogenesis was STIM2 dependent. To prove 
that, we transiently express STIM2 on STIM2 knockout cells and check whether the delay of 
myogenesis can be rescued. Immunofluorescence staining at 2day after inducing differentiation showed 
that -MHC positive nuclei portion of STIM2 knockout cells (2.85 ± 1.25%) was increased when 
expressing STIM2 (6.09 ± 1.58%) (Figure 9K and L) and MHC-positive cells increased markedly 
(Figure 9 M and N).  
Together, these results demonstrated early upregulation of STIM2 genes, and through its 
signaling, C2C12 myoblast regulate expression of early myogenic genes. This phenomenon gave rise 










Figure 11. STIM2β knockout delayed C2C12 myoblast differentiation. 
 
A) Comparative myogenin and MHC mRNA expression by RT-PCR between wild-type and 
STIM2β knockout cells. 
B) GAPDH-normalized expression levels of myogenin of wild-type cells (Black circle) and 
STIM2β knockout cells (White circle) during myogenesis. 
C) GAPDH-normalized expression levels of MHC of wild-type cells (Black circle) and STIM2β 
knockout cells (White circle) during myogenesis. 
D) Immunoblot analysis of wild-type cells and STIM2β knockout cells to measure the protein 
expression of myogenin and MHC during myogenesis. 
E) Actin-normalized expression levels of Myogenin of wild-type cells (Black circle) and STIM2β 
knockout cells (White circle). 
F) Actin-normalized expression levels of MHC of wild-type cells (Black circle) and STIM2β 
knockout cells (White circle). 
G) Immunofluorescence staining of myogenin protein during the differentiation of wild-type cells 
(top) and STIM2β knockout cells (bottom).  
H) Myogenin positive nuclei population of wild-type cells (Black circle) and STIM2β knockout 
cells (White circle). (n > 80 cells for each group). 
I) Immunofluorescence staining of MHC protein during the differentiation of wild-type cells 
(Top) and STIM2β knockout cells (Bottom). 
J) The fraction of MHC positive cells of wild-type cell (Black circle) and STIM2β knockout cells 
(White circle). (n > 80 cells for each group). 
K) Immunofluorescence staining of myogenin protein during the differentiation of wild-type cells 
(Top), STIM2β knockout cells (Middle) and transiently STIM2β expressed STIM2β knockout 
cells (Bottom). (n > 80 cells for each group). 
L) Histogram of myogenin protein during the differentiation of wild-type cells (black bar), 
STIM2β knockout cells (White bar) and transiently STIM2β expressed STIM2β knockout cells 
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(gray bar). (n > 80 cells for each group).  
M) Immunofluorescence staining of MHC protein during the differentiation of wild-type cells 
(Top), STIM2β knockout cells (Middle) and transiently STIM2β expressed STIM2β knockout 
cells (Bottom, gray bar). (n > 80 cells for each group). 
N) Histogram of MHC protein during the differentiation of wild-type cells (black bar), STIM2β 
knockout cells (White bar) and transiently STIM2β expressed STIM2β knockout cells (gray 
bar). (n > 80 cells for each group).  
Error bars show means ± SEM. (All scale bars: 20 μm.) The results are representative of at 
least three independent experiments. 
 
 
3.2.4. STIM2 regulate myogenesis via NFAT4 and MEF2c.  
  
My results thus far set forth the idea that STIM2 regulates myogenesis by cell state switch 
between proliferation and differentiation. We, therefore, want to find out a critical calcium-dependent 
myogenesis transcriptional factor which regulated by STIM2 signaling. The GAPDH normalized 
expression of NFAT4, which well known as a positive regulator of skeletal muscle differentiation, was 
gradually increased in wild-type cells. This result consistent with a previous report (ref). However, the 
expression of NFAT4 gene was rapidly decreased after inducing differentiation in STIM2 knockout 
cells (Figure 10A and B).  
Moreover, the myocyte enhancer factor 2 (MEF2), which known as a central regulator of skeletal 
muscle development (ref), was strongly inhibited in STIM2 knockout cells and fail to make a positive 
feed-forward loop even after inducing differentiation (Figure 10A and C). To further confirm the 
abolished MEF2c expression level was STIM2 signaling dependent, we check the fraction of MEF2 
positive cells with transiently expressing STIM2 on wild-type cells. When 3days after inducing 
differentiation, while the only 30% of wild-type cells showed MEF2 positive cells, around 45% of 
STIM2 expressed cells showed MEF2 positive (Figure 10D and E). Furthermore, the significantly 
decreased MEF2 positive cells of STIM2 knockout cells was rescued by transient expressing of 
STIM2 on knockout cells (Figure 10F), and the decreased MEF2 positive nuclei was rescued by the 
expression of STIM2 (Figure 10G). 
Overall, my data indicate that STIM2 knockout cells fail to make a positive feed-forward loop of 
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critical myogenic genes, NFAT4 and MEF2c. These findings suggest that up-regulation of the STIM2 
gene during myogenesis helps myoblast cells to ignite the driving force to start skeletal muscle 





Figure 12. STIM2β knockout inhibited NFAT4 and MEF2C. 
 
A) Comparative NFAT4 and MEF2c mRNA expression by RT-PCR between wild-type and 
STIM2β knockout cells. 
B) GAPDH-normalized expression levels of NFAT4 of wild-type cells (Black circle) and STIM2β 
knockout cells (White circle) during myogenesis. 
C) GAPDH-normalized expression levels of MEF2c of wild-type cells (Black circle) and STIM2β 
knockout cells (White circle) during myogenesis. 
D) Immunoblot analysis of wild-type cells and STIM2β knockout cells to measure the protein 
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expression of MEF2C during myogenesis. 
E) Actin-normalized expression levels of MEF2C in wildtype cells (Black circle) and STIM2β 
knockout cells (White circle). 
F) The fraction of MEF2c positive nuclei of wild-type cell (Black circle) and STIM2β over-
expressed cells (White rectangular). (n > 60 cells for each group) 
G) The fraction of MEF2c positive nuclei of wild-type cell (Black circle), STIM2β knockout cells 
(White circle) and transiently STIM2β expressed STIM2β knockout cells (Black rectangular). 
(n > 60 cells for each group). 
 
 
3.2.5. STIM2 regulates proliferation via Ca
2+
 homeostasis in C2C12 myoblast cells. 
 
Since myogenesis is accompanied by decreased cell proliferation, the transition from proliferation 
to differentiation is an important and irreversible checkpoint of myogenesis. Therefore, I investigated 
the effects of STIM2 knockout on the proliferation of C2C12 myoblasts using an MTT assay. After 
culture in growth medium for 3 days, the growth of the wild-type cells increased by 4-fold based on the 
change in the MTT-based OD value, while the STIM2 knockout cells increased by 8-fold (Figure 11A). 
To confirm this result, equal numbers of cells were seeded on the growth medium and counted 72 h 
later. Consistently, STIM2 knockout cells showed 3-fold higher cell numbers than those in wild-type 
cells (Figure 11B), confirming that STIM2 knockout promotes the proliferation of C2C12 myoblasts.  
 
To validate the effects of STIM2 knockout, we investigated the Ca2+ signaling in the STIM2 
knockout cell line. Due to STIM2 mainly regulate Ca2+ homeostasis in basal condition and in the 
previous study report that overexpression of STIM2 caused a decrease of resting cytosolic Ca2+ level 
(ref), we measure the intracellular Ca2+ level at resting state by using Fura2-AM dye. To consistent with 
the previous data, STIM2 knockout cells showed a slight but significant increased cytosolic Ca2+ level 
than wild-type C2C12 myoblast. Also, this increased cytosolic Ca2+ level was reduced by transient 
expressing STIM2 genes in knockout cells (Figure 11C and D).  
 
Furthermore, I performed EdU staining in standard Ca2+ concentration (2mM) and high Ca2+ 
concentration (10mM) growth media. Interestingly, both wild-type and STIM2 knockout cells had a 
significantly increased fraction of EdU positive cells when grown in high Ca2+ concentration (10mM) 
56 
 
compared to that under a standard Ca2+ concentration (2mM). Moreover, the STIM2 knockout cells 
showed a tendency to be more sensitive to the Ca2+ concentration (Figure 11E-F). Hence, the increase 
in the intracellular Ca2+ concentration in the absence of STIM2 likely contributed to the increased 





Figure 13. STIM2β knockout promoted proliferation via Ca2+ homeostasis in C2C12 myoblast cells.  
 
A) MTT Proliferation assay of wild-type cells (Black circle) and STIM2β knockout cells (White 
circle). (n = 4 respective experiment for each group) 
B) Histogram of cell population of wild-type cells (Black bar) and STIM2β knockout cells (White 
bar). 
C) Fura-2 Ca2+ measurements in 2 mM Ca2+ Tyrode’s solution. wild-type (black), STIM2β 
knockout cells (blue) and transiently STIM2β expressed in STIM2β knockout cells (green). 
D) Histogram of basal calcium level of wild-type (black), STIM2β knockout cells (white) and 
transiently STIM2β expressed in STIM2β knockout cells (gray). (n > 40 cells for each group)  
E) Fura-2 Ca2+ measurements in Tyrode’s solution. wild-type (black), STIM2β knockout cells 
(blue) in 2 mM extracellular Ca2+ Tyrode’ solution and wild-type (yellow), STIM2β knockout 
cells (green) in 10 mM extracellular Ca2+ Tyrode’ solution. 
F) Histogram of basal calcium level of wild-type (black), STIM2β knockout cells (white). (n > 30 
cells for each group) 
G) (Edu staining of C2C12 wild-type cells in 2 mM and 10 Mm Ca2+ medium. 
H) (Edu staining of C2C12 STIM2β knockout cells in 2 mM and 10 Mm Ca2+ medium.  
I) Histogram of Edu positive nuclei of wildtype cells and STIM2β knockout cells cultured in 2 
mM or 10 mM Ca2+ medium. (n > 80 cells for each group) 
Error bars show means ± SEM. (All scale bars: 20 μm.) The results are representative of at 
least three independent experiments. 
 
 
Together, this result indicates that STIM2 regulates Ca2+ homeostasis of C2C12 myoblast and by 
up-regulation of the STIM2 gene, C2C12 myoblast can efficiently regulate the dynamic Ca2+ signaling 
during skeletal muscle differentiation. 
 
We next asked whether the increased proliferation of STIM2 knockout cells is came from the 
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abnormal intracellular homeostasis of the Ca2+ level in STIM2 knockout cells. To do that, we perform 
Edu staining in standard Ca2+ (2mM) and high Ca2+ (10mM) growth media. Interestingly, both wild-
type and STIM2 knock out cells showed significantly increased the fraction of Edu positive cells in 
high Ca2+ growth media. Also, to my surprise, the wild-type C2C12 myoblast cells in high Ca2+ growth 
media showed slightly higher, but not significant, proliferation than STIM2 knockout cells in standard 
Ca2+ growth media. Moreover, there was a tendency that the STIM2 knockout cells are more sensitive 
to Ca2+ level of growth media (Figure 11 G-I). Taken together, these results implied that STIM2 
regulate the homeostasis of the Ca2+ level, that tightly relates with the proliferation of C2C12 myoblast 
cells.  
 
3.2.6. STIM2 knockout impaired switch proliferation to the differentiation process. 
 
To gain further insights into the mechanism by which STIM2 regulates proliferation and 
differentiation of C2C12 myoblast cells, we performed the EdU assay for detect S-phase cells 
population on wild-type and STIM knockout cells after 24hours stained in growth media (10% FBS, 
DMEM). Interestingly, STIM2 knockout cells do not showed a withdraw from the cell cycle after 
myogenesis was induced, while wild-type cells rapidly withdraw from the cell cycle at 12 and 24 h after 
inducing myogenesis (Figure 12A-E). These results demonstrated that the role of STIM2 on the cell-
cycle arrest during myogenesis. 
Next, I check the cell cycle regulatory genes that control exit from cell cycle (G1-G0 transition). In 
a Quantitative real-time polymerase chain reaction, the expression of cyclin D1 was more stable in the 
STIM2 knockout cells during differentiation process. To confirm this result, we measured the protein 
levels of cyclin D1 and CDK4 during myogenesis in wild-type and STIM2 knockout cells. Surprisingly, 
we found that the protein level of CyclinD1 and CDK4 was gradually decreased during myogenesis in 
wild-type cells. In contrast, STIM2 knockout cells showed increased and stable protein level of 
CyclinD1 and CDK4 (Figure 12 F-H). To further interrogate whether the stable protein expression of 
cyclin D1 in STIM2 knockout cells could induce the transcriptional activity of cyclin D1, I measured 
cyclin D1 positive nuclei portion. After inducing 1day differentiation, only 25% of wild-type cells 











Figure 14. STIM2β knockout inhibited CyclinD1-CDK4 mediated cell cycle arrest.  
 
A) Edu staining of C2C12 wild-type at GM , 12h in DM and 24h in DM. 
B) Edu staining of C2C12 wild-type and STIM2β knockout cells. 
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C) Histogram of Edu positive nuclei of wild-type and STIM2β knockout cells in GM.  
D) Histogram of Edu positive nuclei of wild-type and STIM2β knockout cells 12 h in DM.  
E) Histogram of Edu positive nuclei of wild-type and STIM2β knockout cells 24 h in DM (E). (n 
> 80 cells for each group)  
F) Immunoblot analysis of wild-type cells and STIM2β knockout cells to measure the protein 
expression of CyclinD1 and CDK4 during myogenesis  
G) Actin-normalized expression levels of CyclinD1 of wild-type cells (Black circle) and STIM2β 
knockout cells (White circle). 
H) Actin-normalized expression levels of CDK4 of wild-type cells (Black circle) and STIM2β 
knockout cells (White circle). 
I) Immunofluorescence analysis of cyclin D1 expression in GM and DM 24 h  
J) The relative quantification reporting the cyclin D1-positive nuclei percentage. (n > 130 cells 
for each group) 
Error bars show means ± SEM. (All scale bars: 20 μm.) The results are representative of at 
least three independent experiments. 
 
Collectively, these results indicated that STIM2 knockout stabilized cyclinD1 and its catalytic 
partner CDK4 expression level, which cause promote proliferation and fail to switch from proliferation 
state to differentiation state by block the exit of cell cycle even after inducing differentiation in STIM2 










In the first part of my research, I suggest previously not proposed the gating mechanism of the C. 
elegans SOC channels. In brief, my gating model hypothesis is the C.Orai1 channel protein has two 
flexible states, open and closed. Also, the 2-3 loop of C.Orai1 binding with the C.STIM1 and displaces 
both external N- and C-terminus to change Orai1 channels states from closed to open. 
The noble finding that the activation mechanism of SOCE in nematode has distinct features 
compared with well- known mammals SOCE. In the previous study, N- and C- terminus of mammalian 
Orai channel proteins are reported the binding and gating domains. Interestingly, in this study, my 
results demonstrated a new concept of the Orai channel protein gating mechanism that 2-3 loop of 
C.Orai1 plays a central domain for the STIM1 binding, oligomerization, and gating of Orai channel.   
Furthermore, theoretically, my results provide evidence that Orai channel proteins have evolved with 
altering channel dimerization sites and STIM binding, activation site as a component of SOCE, from 
the 2-3 loop of internal C.Orai1 to the external N- and C- terminus of mammals Orai1. 
This alteration might help Orai channel proteins be tightly regulated finer and easier by many partner 
proteins with maximized accessibility. 
In previous, other groups have suggested many types of gating mechanism in ion channels such as 
the electrostatic switches model and girdle model, which involved by polar residue salt bridges and 
hydrophobic residues, respectively (59, 60). In this study, I proposed that the highly conserved 
hydrophobic amino acids (F and Y) within the internal 2-3 loop of C.Orai1 play a crucial role in C.Orai1 
gating mechanism. Interestingly, FY-RH which neutralizing mutation produced constitutively active 
Orai1 channel even in the absence of STIM1. These results indicated that the process of gating of the 
pore was regulated by the hydrophobic interaction for the elongated path for ions at the resting state. In 
a further study, the detail of the molecular mechanism of how the conformational switch of the 2-3 loop 
switches with the pore-lining helices to gate ions should be addressed. However, at least, my results 
suggested that the possible new molecular mechanism that the external N-terminus of C.Orai1 was 
needed for ion channel gating through the intramolecular switch by the hydrophobic interaction. 
It is a significant research tool that detecting the conformational change of proteins to observed 
interaction or altered activation states to understanding the detailed mechanism occurring in protein 
functions without interrupts the physiological conditions in intact cells. Until now, there are a series of 
approaches that have been proposed for detecting the conformational changes of proteins such as FRET 
and BiFC. Although there many improvements of techniques for detecting the changes of membrane-
anchored channels proteins in intact cells, there still exist challenge points such as its fast and very slight 
alteration between basal and activated states. In this study, I added circularly permutated Venus 
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(cpVenus) into the external N-terminus of Orai1. This approach provided highly informative insights 
into mechanical change between open and closed states of C.Orai1. 
In the second part, I have shown that a novel splicing form of STIM2, STIM2, is required for 
C2C12 myogenesis. STIM2 differs in various points from STIM2. Although STIM2 was initially 
described as a SOCE inhibitor(34, 35), this was determined artifact of overexpression. Therefore, 
STIM2 was a unique inhibitor form of SOCE among all known STIM isoforms. In the previous study 
reported that even small increases in the STIM2/STIM2 ratio could produce inhibition of SOCE. 
Also, STIM2 expression increases during the C2C12 myogenesis suggested that STIM2 will play an 
essential role in the C2C12 myogenesis. However, underlying detail mechanism of STIM2 on C2C12 
myogenesis remain elusive. In this study, I found that the STIM2 act as a positive regulator of 
myogenesis by activating MEF2C and NFAT4 signaling pathway. Also, STIM2 promotes cell cycle 
arrest by inducing degradation of CyclinD1 and its catalytic partner CDK4. 
I also provide evidence that STIM2 is essential for intracellular Ca2+ signaling in myogenesis. An 
interesting finding from Edu staining at the various Ca2+ concentration was that proliferation of C2C12 
myoblast cells was susceptible to Ca2+ level, and this phenomenon was more pronounced in STIM2 
knockout cells. Also, an increased basal Ca2+ level of STIM2 knockout cells was set forth that STIM2 
related with intracellular Ca2+ signaling and STIM2 dependent Ca2+ signaling is required for fine-
tuning of the proliferation of C2C12 myoblast cells.  
Its high evolutionary conservation and the widespread expression of STIM2 gene gave rise to the 
importance of STIM2 in various physiological function. Also, generation of STIM2 through 
alternative splicing is a particularly useful way of modulating SOCE. Although increasing numbers of 
evidence about the importance of SOCE in multiple developmental defects (e,g., in muscle, sweat 
glands, and tooth enamel), most current studies reported that cases of defects carried by mutations in 
STIM or Orai genes which induce entirely abolished SOCE. Thus, the function of STIM2 on 
myogenesis provide importance about not only an effective way to modulation of SOCE within skeletal 
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그 무엇보다도, 저의 지도교수님 이신 박찬영 교수님의 성실하고, 끝없는 동기부여, 열
정, 과학자 로서의 멘토링, 그리고 그 엄청난 지식과 지혜에 감사를 표하고 싶습니다. 멋모르는 
학부생 시절부터 실험실에 들어와 랩구성원으로 자리잡을 수 있도록 기회를 제공해 주신 것부터 
시작하여, 학문적 차원에서 저에게 연구 문제를 정의하고, 해결책을 찾고, 마무리를 하여 연구 
결과를 발표하는 방법을 가르쳐 주셔서 감사합니다. 학문 외 적인 면에서도 교수님의 진실되고 
진심인 자세와 노력은 저에게 항상 영감을 주었습니다. 다시한번, 부족한 제가 교수님의 지도하
에 연구하였다는 것에 언제나 감사드리고 교수님의 첫 박사과정 학생이라는 것에 영광의 마음을 
작게 나마 표현합니다.  
또한 바쁘신 와중에도 한없이 부족하기만 한 저의 논문심사를 해주시고 아낌없는 조언을 해 주
신 박태주 교수님, 강세병 교수님, 채영찬 교수님 그리고 백충기 교수님께 깊은 감사인사를 드립
니다.  
그리고 박사학위 과정 동안 부족한 저의 프로젝트의 완성을 위해 같이 노력해주시고 고민해주
신 이규필 교수님과 언제나 까다로운 현미경 실험조건을 가지고 찾아가도 해답을 찾아 주시고 실
마리를 제공해 주신 허진회 선생님, 저에게 연구자 로서의 자세와 선함의 가치를 알려주신 김인
형 선생님께도 감사인사를 드립니다.  
또한, 실험실이라는 특수한 환경에서 만나 각자의 목표를 향해 열심히 달려나가고 있는 상권, 
영천, 아름, 수지, 윤영에게 감사인사를 드립니다. 동기로서, 사수로서, 한없이 부족하고 채울 
점이 많던 저지만 함께 했던 시간이 각자 길을 달려가다가 문득 생각 했을 때 행복했던 추억으로 
기억됐으면 합니다. 그리고 지금은 실험실을 떠나 길을 개척하고 있는 피디님 준섭이형, 내 영원
한 룸메이트였던 상현이형, 언제나 내 멘토였던 현선누나 현정누나, 제대로 사수역활을 못하거나 
힘들 때 도움이 많이 되어주지 못해 미안했던 준호, 기현, 동현이, 성국이 모두가 항상 행복했으
면 합니다.  
마지막으로 길고도 길었던 학위과정동안 언제나 응원해주시고 격려해주신 나의 어머니, 아버
지, 형, 동생 언제나 내 욕심이 우선이라 많은 도움이 되지 못해서 죄송하고 사랑합니다.  
